arXiv:2411.02413v1  [q-bio.TO]  20 Oct 2024
A phenotype-structured mathematical model for the inï¬‚uence of
hypoxia on oncolytic virotherapyâˆ—
David Morselli,â€ â€¡Â§Â¶
Giulia Chiari,â€–â€¡Â§Â¶
Federico Frascoli,Â§
Marcello Edoardo Delitalaâ€¡
November 6, 2024
Abstract
The eï¬€ectiveness of oncolytic virotherapy is signiï¬cantly aï¬€ected by several elements of the tumour
microenvironment, which reduce the ability of the virus to infect cancer cells. In this work, we focus on the
inï¬‚uence of hypoxia on this therapy and develop a novel continuous mathematical model that considers both
the spatial and epigenetic heterogeneity of the tumour. We investigate how oxygen gradients within tumours
aï¬€ect the spatial distribution and replication of both the tumour and oncolytic viruses, focusing on regions
of severe hypoxia versus normoxic areas. Additionally, we analyse the evolutionary dynamics of tumour cells
under hypoxic conditions and their inï¬‚uence on susceptibility to viral infection. Our ï¬ndings show that
the reduced metabolic activity of hypoxic cells may signiï¬cantly impact the virotherapy eï¬€ectiveness; the
knowledge of the tumourâ€™s oxygenation could, therefore, suggest the most suitable type of virus to optimise
the outcome. The combination of numerical simulations and theoretical results for the model equilibrium
values allows us to elucidate the complex interplay between viruses, tumour evolution and oxygen dynamics,
ultimately contributing to developing more eï¬€ective and personalised cancer treatments.
Keywordsâ€” Oncolytic virus, hypoxia, tumour phenotypic heterogeneity, continuous structured models
1
Introduction
Among cancer therapies, oncolytic virotherapy stands out as a promising avenue that harnesses the natural capabilities
of viruses to selectively target and destroy cancer cells while sparing healthy tissues, [13, 28, 43, 47, 70]. Despite its
potential, the clinical eï¬ƒcacy of oncolytic virotherapy faces signiï¬cant challenges, many of which stem from the complex
dynamics of the tumour microenvironment (TME) [40, 83].
âˆ—Corresponding author: David Morselli (d.morselli@ucl.ac.uk)
This research was partially supported by the Italian Ministry of Education, University and Research (MIUR) through the â€œDipar-
timenti di Eccellenzaâ€ Programme (2018-2022) â€“ Dipartimento di Scienze Matematiche â€œG. L. Lagrangeâ€, Politecnico di Torino
(CUP: E11G18000350001). DM, GC and MED are members of GNFM (Gruppo Nazionale per la Fisica Matematica) of INdAM
(Istituto Nazionale di Alta Matematica). We also acknowledge the support of the Australian National Health and Medical Research
Council, through grant NHMRC IDEAS 2013058. Part of this work was performed on the OzSTAR national facility at Swinburne
University of Technology. The OzSTAR program receives funding in part from the Astronomy National Collaborative Research
Infrastructure Strategy (NCRIS) allocation provided by the Australian Government, and from the Victorian Higher Education
State Investment Fund (VHESIF) provided by the Victorian Government.
â€ Department of Mathematics, University College London, 25 Gordon Street, London WC1H 0AY, United Kingdom
â€¡Department of Mathematical Sciences â€œG. L. Lagrangeâ€, Politecnico di Torino, Corso Duca degli Abruzzi 24, 10129 Torino,
Italy
Â§Department of Mathematics, School of Science, Computing and Engineering Technologies, Swinburne University of Technology,
John St, 3122, Hawthorn, VIC, Australia
Â¶Department of Mathematics â€œG. Peanoâ€, Universit`a di Torino, Via Carlo Alberto 10, 10124 Torino, Italy
â€–BCAM â€“ Basque Center for Applied Mathematics, Mazarredo Zumarkalea, 14, Abando, 48009 Bilbo, Spain
1
The TME signiï¬cantly inï¬‚uences viral distribution and therapeutic eï¬ƒcacy.
Factors such as extracellular matrix
composition, immune cell inï¬ltration and hypoxic regions can impede viral penetration, replication and spread within
the tumour. These barriers create unpredictable, stochastic events that aï¬€ect the consistency of viral delivery and the
overall success of the therapy. Another interesting interaction involves the neovasculature that the tumour originates
through angiogenesis: most oncolytic viruses disrupt it by targeting tumour-associated vascular endothelial cells [40, 83].
On the one hand, the decrease in nutrient inï¬‚ow contributes to slowing down cancer growth and, in this respect, oncolytic
virotherapy could act in the same way as antiangiogenic therapy. On the other hand, blood vessels also play a vital role
in the arrival of viral particles and immune cells [72].
The inadequate vascularisation within tumours reduces oxygen availability: this hypoxic condition is a hallmark of solid
tumours, signiï¬cantly aï¬€ects the tumourâ€™s evolution and profoundly impacts treatment eï¬ƒcacy [87]. Hypoxic regions
within tumours promote aggressiveness by harbouring cells with reduced metabolic activity and heightened resistance to
therapies. In the context of oncolytic virotherapy, the impact of hypoxia on therapeutic eï¬ƒcacy is twofold [73]. Firstly,
hypoxic regions within tumours harbour cells less susceptible to viral infection and replication due to reduced metabolic
activity and altered cellular signalling pathways. Secondly, the physiological adaptations of tumour cells to hypoxia,
such as enhanced glycolytic metabolism and resistance to apoptosis, can confer resistance to viral-induced cell death. It
is important to remark that the previous considerations are not universal: indeed, some particular oncolytic viruses can
speciï¬cally target receptors that are upregulated in case of the lack of oxygen [71, 73].
Understanding how hypoxia inï¬‚uences the interaction between OVs and tumour cells is crucial for optimising treatment
strategies and overcoming therapeutic resistance. Mathematical modelling is pivotal in unravelling these complexities
and optimising therapeutic outcomes. The dynamics of viral replication and tumour growth have been analysed through
several modelling approaches, ranging from ordinary diï¬€erential equations (ODEs) [2, 24, 75, 79, 37, 39, 46, 61, 81]
and partial diï¬€erential equations (PDEs) [3, 30, 29, 45, 66, 85, 86] to stochastic agent-based models [36, 74, 76, 82]
and hybrid multi-scale models [38, 62].
Some of these models also take into account aspects related to the tumour
microenvironment, such as spatial constraints due to the extracellular matrix [3, 38, 45, 66] and interactions with the
immune system [2, 24, 75, 79, 29, 38, 81, 86]. Only a few mathematical models describe virotherapy in hypoxic conditions.
In Ref. [68], the authors consider ODEs and nested ODEs (corresponding to infections in adjacent lymph nodes) under
the assumption that oxygen concentration directly inï¬‚uences the infection rate. The only spatial model that we know in
this context is the one presented in Ref. [14], in which the diï¬ƒculties of treating hypoxic regions with standard therapies
motivate the use of macrophages that release oncolytic viral particles when experiencing low oxygen concentrations. The
lack of spatial models that consider the inï¬‚uence of oxygen concentration on virotherapy eï¬€ectiveness motivates the
present work.
In the absence of viral infection, several approaches have been developed to understand the inï¬‚uence of hypoxia on
tumour dynamics, using either discrete compartments that evolve according to diï¬€erent dynamics [8, 34, 55, 69] or
a continuous spectrum of adaptation levels [5, 6, 32]. The latter approach in the continuous settings leads to integro-
diï¬€erential equations (IDEs) and, when spatial heterogeneity is included, to partial integro-diï¬€erential equations (PIDEs)
[19, 26, 53, 77]. We build upon this modelling approach and consider the heterogeneous eï¬€ects of oncolytic virotherapy
within the framework of spatial and phenotypic variability.
A common characteristic of continuous structured models is the presence of a trade-oï¬€between diï¬€erent features, in
the sense that the increase of a speciï¬c ability corresponds to the decrease of a diï¬€erent trait: in the context of hypoxia,
this trade-oï¬€usually involves the proliferation rate and the resistance to hypoxic conditions; in the case of infections,
one may consider a trade-oï¬€involving the susceptible compartment between proliferation rate and resistance to the
infection [52]. In this work, we combine both trade-oï¬€s and assume that less proliferative cells have slower metabolic
activity, resulting in a higher resistance to hypoxic conditions and a lower infection rate in the presence of oncolytic
virus. More in detail, our model incorporates both spatial and phenotypic heterogeneity of tumour cells, along with the
dynamics of oxygen concentration and viral infection; the model is formulated using a combination of partial diï¬€erential
equations (PDEs) and partial integro-diï¬€erential equations (PIDEs), explicitly accounting for the spatial gradients of
oxygen within the tumour. Such a modelling approach allows us to perform a formal asymptotic analysis of simpliï¬ed
settings to compute the homogeneous equilibrium values.
It is important to remark that the use of a continuous trait variable to describe the systemâ€™s heterogeneity has been
widely employed for equations that share some formal similarities to the ones analysed in the present work, both in
the epidemiological settings [1, 11, 50, 52] and the ecological settings [20, 21].
In oncolytic virotherapy, structured
2
populations have been used in Ref. [23] in relation to the time from infection and in Ref. [41] to model various kinds
of heterogeneity, including susceptibility to infections, death rates, and virulence; neither of them considers trade-oï¬€s
similar to the ones we aim to investigate. As previously mentioned, in this work, we build upon the model presented in
Ref. [52] and include spatial heterogeneity and environmental factors that inï¬‚uence the dynamics (as in Refs. [19, 18]);
to our knowledge, both aspects constitute a novelty with respect to the existing literature.
In this work, we aim to
- characterise the impact of hypoxia on viral infection and investigate how oxygen gradients within tumours aï¬€ect
the spatial distribution and replication of the tumour and the oncolytic viruses, with a focus on regions of severe
hypoxia versus normoxic areas;
- explore evolutionary dynamics and analyse how hypoxia-induced adaptations in tumour cells inï¬‚uence their sus-
ceptibility to viral infection, the epigenetic composition of the tumour, and the emergence of resistant phenotypes
over time;
- consider the trade-oï¬€between proliferation rate and resistance to hypoxia in view of optimising therapeutic strate-
gies to enhance the eï¬ƒcacy of oncolytic virotherapy in hypoxic tumour environments.
The rest of the paper is organised as follows: Section 2 provides the mathematical formulation of the model, detailing
the integration of viral dynamics, tumour evolution, and spatial oxygen gradients, and a brief theoretical analysis. In
Section 3, we present numerical simulations and explore the impact of hypoxia on the eï¬ƒcacy of oncolytic virotherapy;
we also mention the situation of a virus that speciï¬cally targets hypoxic cells, looking towards the combination of several
therapies. Section 4 concludes the paper by summarising the key ï¬ndings and discussing the implications of these ï¬ndings
for optimising treatment strategies.
2
Modelling framework
We consider the epigenetic heterogeneity of uninfected cancer cells and assume that it aï¬€ects resistance to hypoxia in
addition to proliferation and infection. The dynamics of infected cells, instead, are not aï¬€ected by epigenetic charac-
teristics, hence we model them as a homogeneous population. We ï¬rst describe the model and then carry out a simple
asymptotic analysis to characterise the equilibrium of the problem under the assumption of stationary oxygen.
2.1
Model description
Let us denote by t âˆˆ[0, +âˆ) the time variable, by x âˆˆâ„¦the space variable, with â„¦âŠ‚R2 and by y âˆˆY the epigenetic
variable, with Y := [0, 1]. We consider uninfected and infected cancer cells, whose densities are described respectively
by the functions u: [0, +âˆ) Ã— â„¦Ã— Y â†’[0, +âˆ) and I : [0, +âˆ) Ã— â„¦â†’[0, +âˆ). We also deï¬ne the uninfected total cell
density as
U(t, x) :=
Z
Y
u(t, x, y) dy
(2.1)
and the total cancer cell density as
Ï(t, x) := I(t, x) + U(t, x, y)
(2.2)
Finally, we consider viral density, described by the function v: [0, +âˆ) Ã— â„¦â†’[0, +âˆ), and oxygen concentration,
described by the function O: [0, +âˆ) Ã— â„¦â†’[0, +âˆ). We now describe in detail the rules governing all the dynamics.
Uninfected cancer cells
Uninfected cells may move via pressure-driven movement, change their epigenetic trait,
reproduce, become infected and die due to environmental selection. We assume a trade-oï¬€between proliferation and
resistance to both hypoxia and viral infection. In this sense, we consider y as the level of expression of a set of genes
responsible for this trade-oï¬€and normalise it so that y = 0 and y = 1 are, respectively, the lowest and highest possible
expressions: y = 0 corresponds to highest intrinsic proliferation rate, lowest resistance to hypoxia and highest infection
3
rate; conversely y = 1 corresponds to lowest intrinsic proliferation rate, highest resistance to hypoxia and lowest infection
rate. The evolution of uninfected cells is described by the equation
âˆ‚tu(t, x, y) =R(y, Ï(t, x), O(t, x), v(t, x)) u(t, x, y)
+ Dy âˆ‚2
yyu(t, x, y)
|
{z
}
random mutation
+ Dx divx Â·(u(t, x, y)âˆ‡Ï(t,x))
|
{z
}
pressure-driven movement
with
R(y, Ï, O, v) =
 P(y, Ï)
| {z }
proliferation
âˆ’S(y, O
| {z }
selection
)

âˆ’Î²(y) v
| {z }
infection
Random epigenetic mutations are described by a diï¬€usive term in y with coeï¬ƒcient Dy. Cancer cells also move with
coeï¬ƒcient Dx in space against the gradient of the total cancer cell density Ï(t, x). Furthermore, uninfected cancer cells
proliferate at a rate determined by the intrinsic proliferation rate p(y) and the local cancer cell density Ï(t, x), according
to the logistic growth term
P(y, Ï) = p(y)

1 âˆ’Ï
K

(2.3)
Uninfected cells may also die because of the environmental selection driven by oxygen concentration. The ï¬ttest trait,
according to oxygen availability, is determined by the function
Ï•(O) :=
ï£±
ï£´
ï£´
ï£´
ï£´
ï£²
ï£´
ï£´
ï£´
ï£´
ï£³
1
if O â‰¤Om
OM âˆ’O
OM âˆ’Om
if Om < O < OM
0
if O â‰¥OM
(2.4)
Thus, the selective term is expressed through a quadratic function of the distance of trait y from the ï¬ttest one:
S(y, O) = Î·(y âˆ’Ï•(O))2
(2.5)
where Î· deï¬nes the time scale at which the process takes place. Finally, the virus infects uninfected cancer cells according
to the density of virions and the infection rate Î²(y).
Note that y is directly involved in the selection term; it also aï¬€ects proliferation and infection through the coeï¬ƒcients
p(y) and Î²(y). To catch the above-described trade-oï¬€, we set
p(y) = pM âˆ’(pM âˆ’pm)y,
Î²(y) = Î²m + (Î²M âˆ’Î²m)y
(2.6)
Observe that both functions are increasing in y.
We remark that the terms for proliferation and selection are the same ones adopted in Ref.
[19].
In absence of
infections, the cell density always grows up to the same carrying capacity K irrespective of the oxygen level: this
constitutes a signiï¬cant diï¬€erence with respect to some previous modelling approaches of hypoxic tumours (such as the
ones employed in Refs. [5, 4, 26, 78]) and allows us to consider virotherapy as the only cause of cancer reduction in
hypoxic conditions.
Infected cancer cell
Infected cells may move and die; uninfected cells may also become infected. The dynamics are
described by the equation
âˆ‚tI(t, x) = Dx div(I(t, x)âˆ‡Ï(t, x))
|
{z
}
pressure-driven movement
+ v(t, x)
Z
Y
Î²(y)u(t, x, y) dy
|
{z
}
infection
âˆ’qII(t, x)
|
{z
}
death
The movement follows the same law as that of uninfected cells, as there is no reason to assume that the infection has
some eï¬€ect on that. All the susceptible cells that undergo infection are collected in the same population. Finally, infected
cells die at rate qI.
We assume that infected cells do not proliferate, as the virus disrupts the cellular machinery, and are not aï¬€ected by
environmental conditions due to their short life. Consequently, they lack all the processes the epigenetic trait aï¬€ects,
which motivates their absence of epigenetic structure. This approach is the same one adopted in Ref. [52], with the only
diï¬€erences that we here consider a spatial structure and infections mediated by a viral population.
4
Oncolytic virus
The virus is injected into the tumour, then diï¬€uses in space with coeï¬ƒcient Dv and decays with
rate qv. The lysis of an infected cell releases Î± viral particles. The dynamics are described by the equation
âˆ‚tv(t, x) = Dvâˆ†v(t, x)
|
{z
}
diï¬€usion
+ Î±qII(t, x)
|
{z
}
release
âˆ’qvv(t, x)
|
{z
}
natural decay
+ vinj(x)Î´Tinj(t)
|
{z
}
viral injection
(2.7)
The injection is modelled through a Dirac delta, which corresponds to a jump in the viral concentration at time Tinj; the
spatial proï¬le of the injection is given by the function vinj.
Oxygen
The oxygen is delivered by tissue vascularisation with a space-dependent intensity Q(x), diï¬€uses in space
with diï¬€usion coeï¬ƒcient DO and is consumed both by healthy tissue and cancer cells. The resulting equation is
âˆ‚tO(t, x) = DOâˆ†O(t, x)
|
{z
}
diï¬€usion
âˆ’qOO(t, x)
|
{z
}
natural decay
âˆ’
Î»Ï(t, x)O(t, x)
|
{z
}
cancer cell consumption
+ Q(x)
| {z }
source
(2.8)
We assume that healthy cells initially ï¬ll the tissue up to carrying capacity and their oxygen consumption is indirectly
modelled through the decay at rate qO. As the tumour grows, healthy cells are replaced by cancer cells, which consume
more oxygen: the additional consumption is captured by the term Î»Ï(t, x)O(t, x).
Observe that both infected and
uninfected cells are responsible for oxygen consumption in the same way and the epigenetic trait of uninfected cells does
not aï¬€ect the consumption (as already done in Ref. [18]).
Summary of the model
Collecting all the equations together, the evolution of the system reads:
ï£±
ï£´
ï£´
ï£´
ï£´
ï£´
ï£´
ï£´
ï£´
ï£²
ï£´
ï£´
ï£´
ï£´
ï£´
ï£´
ï£´
ï£´
ï£³
âˆ‚tu(t, x, y) = Dyâˆ‚2
yyu(t, x, y) + Dx divx(u(t, x, y)âˆ‡Ï(t,x)) + P(y, Ï(t, x)) u(t, x, y)
âˆ’S(y, O(t, x)) u(t, x, y) âˆ’Î²(y) u(t, x, y) v(t, x)
âˆ‚tI(t, x) = Dx div(I(t, x)âˆ‡Ï(t, x)) + v(t, x)
R
Y Î²(y)u(t, x, y) dy âˆ’qII(t, x)
âˆ‚tv(t, x) = Dvâˆ†v(t, x) + Î±qII(t, x) âˆ’qvv(t, x) + vinj(x)Î´Tinj(t)
âˆ‚tO(t, x) = DOâˆ†O(t, x) âˆ’qOO(t, x) âˆ’Î»Ï(t, x)O(t, x) + Q(x)
Ï(t, x) :=
R
Y u(t, x, y) dy + I(t, x)
(2.9)
with the previously deï¬ned Ï(t, x) in Eq. (2.2), P(y, Ï(t, x)) in Eq. (2.3), S(y, O(t, x)) in Eq. (2.5) based on Ï•(O(t, x))
in Eq. 2.4, and p(y) and Î²(y) set as in Eq. (2.6). We keep the oxygen source Q(x) in general form and change it
according to the biological setting we aim to reproduce.
We deï¬ne the Cauchy problem by imposing the initial conditions: u(0, x, y) = u0(x, y), I(0, x) = 0, v(0, x) = 0,
O(0, x) = O0(x), where u0(x, y) and O0(x) will be deï¬ned in the context of the various scenarios in Section 3; we
always assume that the tumour initially grows without viral infection and the therapy is administered after some time.
Moreover, we impose no ï¬‚ux boundary conditions on âˆ‚Y , i.e. âˆ‚yu(t, x, 0) = âˆ‚yu(t, x, 1) = 0, corresponding to the fact
that the epigenetic trait cannot assume values below 0 or above 1. Finally, we also impose no ï¬‚ux boundary condition
for all u(t, x, y), I(t, x), v(t, x) and O(t, x) at âˆ‚â„¦, meaning that these quantities cannot leave the spatial domain.
2.2
Theoretical insights
The stationary equilibrium values of the system described in Eq. (2.9) can be computed through formal asymptotic
analysis. Building upon the methods employed in Refs. [49, 51, 77], we introduce a small parameter Îµ and assume that
Dx = Îµ,
Dy = Dv = DO = Îµ2
5
Furthermore, we use the time scaling t 7â†’
t
Îµ, which allows us to study the long-time behaviour of the system. The
computations performed in Appendix A show that the equilibria with a persistent infection solve the system
ï£±
ï£´
ï£´
ï£´
ï£´
ï£´
ï£´
ï£´
ï£´
ï£´
ï£´
ï£´
ï£´
ï£´
ï£´
ï£´
ï£´
ï£´
ï£²
ï£´
ï£´
ï£´
ï£´
ï£´
ï£´
ï£´
ï£´
ï£´
ï£´
ï£´
ï£´
ï£´
ï£´
ï£´
ï£´
ï£´
ï£³
Â¯U =
qv
Î±[Î²M + (Î²m âˆ’Î²M)Â¯y]
Â¯v = Î±qI
qv
Â¯I
Â¯O =
Q
qO + Î»( Â¯U + Â¯I)
R(Â¯y, Â¯U + Â¯I, Â¯O, Â¯v) = [pM + (pm âˆ’pM)Â¯y]

1 âˆ’
Â¯U + Â¯I
K

âˆ’Î·(Â¯y âˆ’Ï•( Â¯O))2
âˆ’[Î²M + (Î²m âˆ’Î²M)Â¯y]Â¯v = 0
âˆ‚yR(Â¯y, Â¯U + Â¯I, Â¯O, Â¯v) = (pm âˆ’pM)

1 âˆ’
Â¯U + Â¯I
K

âˆ’2Î·(Â¯y âˆ’Ï•( Â¯O)) âˆ’(Î²m âˆ’Î²M)Â¯v = 0
(2.10)
In Appendix A, we also discuss the case of infection-free equilibria.
The above system is too complicated to be studied analytically; hence, we mainly consider numerical solutions.
Although six solutions exist, only one is biologically meaningful in the parameter range that we consider. A more useful
expression can be obtained by solving the equation âˆ‚yR = 0 in Â¯y:
Â¯y = Ï•( Â¯O) + 1
2Î·
h
âˆ’(pM âˆ’pm)

1 âˆ’Ï
K

+ (Î²M âˆ’Î²m)Â¯v
i
(2.11)
This formula has a straightforward interpretation: Ï•( Â¯O) is the epigenetic trait selected by the oxygen concentration; the
ï¬ttest trait tends to decrease when the total cell population Ï is low due to the diï¬€erent proliferation rates of cell lines
in a situation of low competition; at the same time, it grows in the presence of viral infection that targets proliferative
cells and it reduces if the infection targets hypoxic cells. We remark that this formula may yield a value of Â¯y outside the
interval [0, 1], which has no meaning in our formulation of the model: when this happens, we should expect the ï¬ttest
trait to be 0 if Â¯y < 0 and 1 if Â¯y > 1.
A simpler situation is obtained by assuming that tumour dynamics do not signiï¬cantly aï¬€ect oxygen density so that
Â¯O is given a priori; in this case, the system becomes
ï£±
ï£´
ï£´
ï£´
ï£´
ï£´
ï£´
ï£´
ï£´
ï£´
ï£´
ï£´
ï£´
ï£²
ï£´
ï£´
ï£´
ï£´
ï£´
ï£´
ï£´
ï£´
ï£´
ï£´
ï£´
ï£´
ï£³
Â¯U =
qv
Î±[Î²M + (Î²m âˆ’Î²M)Â¯y]
Â¯v = Î±qI
qv
Â¯I
R(Â¯y, Â¯U + Â¯I, Â¯O, Â¯v) = [pM + (pm âˆ’pM)Â¯y]

1 âˆ’
Â¯U + Â¯I
K

âˆ’Î·(Â¯y âˆ’Ï•( Â¯O))2
âˆ’[Î²M + (Î²m âˆ’Î²M)Â¯y]Â¯v = 0
âˆ‚yR(Â¯y, Â¯U + Â¯I, Â¯O, Â¯v) = (pm âˆ’pM)

1 âˆ’
Â¯U + Â¯I
K

âˆ’2Î·(Â¯y âˆ’Ï•( Â¯O)) âˆ’(Î²m âˆ’Î²M)Â¯v = 0
(2.12)
It is then possible to obtain a third-degree equation for Â¯y, which in principle can be solved; however, the explicit
solutions are still too complicated to give any useful information. Fig. 1 shows the numerical solution of Eq. (2.12)
that is biologically meaningful. In the reference situation (Î²m < Î²M), the equilibrium values of Â¯U and Â¯y increase as
the oxygen values decrease; when the values of Î²M and Î²m are switched, we observe the inverse behaviour. The eï¬€ect
of oxygen variations on Â¯I is more complex, as its value is almost constant for a wide range of oxygen values and then
signiï¬cantly decreases only when the oxygen concentration is very low (or very high).
So far, we have focused our discussion on the spatially homogeneous situation. To our knowledge, spatial dynamics in
this context have not been studied analytically, not even in simpler settings (such as the one of Ref. [52]). Nevertheless,
6
Figure 1: Numerical solution of Eq. (2.12) showing the equilibria in diï¬€erent oxygen conditions. The parameters in
panel (a) take the values listed in Table 1. In panel (b), the values of Î²M and Î²m are switched to reproduce the situation
of oncolytic viruses that speciï¬cally target hypoxic cells. In both cases, Ï•( Â¯O) ranges between 0 and 1.
Parameter
Description
Value [Units]
Reference
pM
maximal duplication rate
2.88 Ã— 10âˆ’2 [hâˆ’1]
[42]
pm
minimal duplication rate
1.44 Ã— 10âˆ’2 [hâˆ’1]
[55]
K
tissue carrying capacity
106 [cells/mm3]
[48]
Dx
cell spatial diï¬€usion coeï¬ƒcient
1.30 Ã— 10âˆ’9 [(mmÃ—cellsÃ—h)]
estimate based on [44]
Î·
selection rate by oxygen
2.08 Ã— 10âˆ’2 [hâˆ’1]
model estimate
Dy
cell epigenetic diï¬€usion coeï¬ƒcient
5.00 Ã— 10âˆ’6 [hâˆ’1]]
[16]
Î²M
maximal infection rate
7.00 Ã— 10âˆ’10 [mm3/(virusesÃ—h)]
[31]
Î²m
minimal infection rate
1.75 Ã— 10âˆ’10 [mm3/(virusesÃ—h)]
model estimate
qI
death rate of infected cells
4.17 Ã— 10âˆ’2 [hâˆ’1]
[33]
qv
virus clearance rate
1.67 Ã— 10âˆ’1 [hâˆ’1]
[57]
Î±
viral burst size
1000 [viruses/cells]
model estimate
Dv
virus diï¬€usion coeï¬ƒcient
3.6 Ã— 10âˆ’2 [mm2/h]
[44]
Omax
maximal oxygen concentration
2.16 Ã— 10âˆ’3 [mm3
O2/mm3
plasma]
[56, 65]
OM
oxygen normoxic threshold
1.71 Ã— 10âˆ’3 [mm3
O2/mm3
plasma]
[56, 65]
Om
oxygen hypoxic threshold
2.28 Ã— 10âˆ’4 [mm3
O2/mm3
plasma]
[56, 65]
qO
oxygen physiological decay rate
5.60 Ã— 102 [hâˆ’1]
estimate based on [80]
Î»
oxygen consumption rate
6.55 Ã— 10âˆ’4 [mm3/(cellÃ—h)]
estimate based on [35]
DO
oxygen diï¬€usion coeï¬ƒcient
3.60 [mm2/h]
[59]
Table 1: Parameter set.
given the forthcoming numerical simulations, it is helpful to recall some elementary facts. If we neglect the epigenetic
structure, the one-dimensional dynamics of uninfected cells in the absence of viral infection follow the equation
âˆ‚tu(t, x) = Dxâˆ‚x(u(t, x)âˆ‚xu(t, x)) + p

1 âˆ’u(t, x)
K

u(t, x)
It is well-known that there exist travelling waves solutions of this equation with speed at least
p
DxKp/2 and an initial
condition with compact support evolves into a wave that travels with the minimal speed [7, 60]. The addition of infection
due to cell-to-cell contact originates travelling waves of the two populations (uninfected and infected), with the uninfected
proliferative cells trying to escape from the infected cells [58]; the addition of a viral population does not signiï¬cantly
change this picture. It is important to remark that an eï¬ƒcient infection results in a wavefront much lower than the
carrying capacity, whose invasion speed is lower than
p
DxKp/2.
7
3
Numerical results
In this Section, we compare numerical simulations with the theoretical results described in the previous Section. The
parameter values are listed in Table 1; in Appendix B, we explain how the values have been chosen, as well as the
numerical method employed.
In all the simulations, we start with an uninfected tumour of the form
u0(x, y) =
ï£±
ï£´
ï£²
ï£´
ï£³
Au e
âˆ’|xâˆ’x0|2
Î¸x
âˆ’(yâˆ’y0)2
Î¸y
if Au e
âˆ’|xâˆ’x0|2
Î¸x
âˆ’(yâˆ’y0)2
Î¸y
> 1
0
otherwise
(3.1)
The truncation is performed in order to have an initial condition with compact support; the form of the equations is
such that the solution will still be compactly supported at all times [7, 60]. In all the simulations we set x0 = (0, 0),
y0 = Ï•(O(0, x0)), Î¸x = 0.5, Î¸y = 0.5. The parameter Au is set to
Au = 7.19 Ã— 104 cell/mm3
Z
Y
e
âˆ’(yâˆ’y0)2
Î¸y
dy
This choice allows a maximal initial total cell density equal to K
10, irrespective of the value of y0. We then assume that
viral injection is performed after some time so that the tumour can adapt to the environment. In most of the cases, we
perform a central viral injection as soon as the tumour reaches a given size: in mathematical terms, we set
Tinj := inf { t âˆˆ[0, +âˆ) | d(t) â‰¥dinj }
(3.2)
where dinj is the tumour size at which we choose to inject the virus and
d(t) := diam

x âˆˆâ„¦
 Ï(x, t) â‰¥K
10

We recall that the diameter of a general set E is deï¬ned as
diam E := sup { |x1 âˆ’x2| | x1, x2 âˆˆE }
In the particular situation of a circle, this deï¬nition coincides with the standard diameter; in the general case, the
diameter is the longest length found inside the set. This choice is based on the assumption that small tumours cannot
be clinically detected, hence the therapy may only start when cancer cells reach a density of at least one tenth of the
carrying capacity in a large region. We set dinj = 5.2 mm, as in [44] and the central viral injection takes the form
vinj(x) = Av eâˆ’|xâˆ’x0|2
Î¸v
(3.3)
with Av = 7 Ã— 109, Î¸v = 0.5.
This allows for a total number of viral particles in agreement with the experiments
performed in [44].
For the sake of simplicity, we ï¬rst consider in Subsection 3.1 a stationary oxygen distribution independent of time,
corresponding to a situation in which the tumour does not inï¬‚uence the oxygen distribution: while this is clearly an
oversimpliï¬cation, it allows us to focus our attention on the tumourâ€™s evolutionary and infectious dynamics. We then
analyse in Subsection 3.2 the full model, which includes oxygen dynamics, taking into account diï¬€erent conï¬gurations
of oxygen sources. Finally, in Subsection 3.3 we brieï¬‚y mention the case of a virus that speciï¬cally infects hypoxic cells,
looking towards the combination of oncolytic virotherapy with other treatments.
8
Figure 2: Results of the numerical simulation without viral infection for stationary oxygenation, for three spatially
homogeneous oxygen condition: O = OM (solid lines), O = OM +Om
2
(dashed lines), and O = Om (dot-dashed lines).
We plot the solutions at time tâˆ—= 1500 h. Only the horizontal section is shown to facilitate the comparison. The blue
lines in the left plot represent the proï¬le of uninfected cancer cells U(tâˆ—, x). In the right plot, the green lines show the
average epigenetic trait Âµ(tâˆ—, x) and the light-blue lines show the ï¬ttest trait selected by the environment Ï•(O(tâˆ—, x)).
3.1
Stationary oxygen
The most elementary situation is obtained by considering that the oxygen concentration is constant in space and time.
We focus on three oxygen values, namely OM (normoxia), Om (severe hypoxia) and their average Om+OM
2
(physiological
hypoxia), whose corresponding selected traits are respectively 1, 0 and 0.5; other values produce intermediate situations.
We then consider inhomogeneous oxygen distributions, which resemble more biologically meaningful situations.
To make the comparison between the epigenetic composition and spatial characterisation more straightforward, we
introduce the average epigenetic trait, deï¬ned as
Âµ(t, x) :=
R
Y u(t, x, y) y dy
U(t, x)
for all (t, x) such that U(t, x) Ì¸= 0
Observe that this condition is not satisï¬ed in the whole domain due to the compact support of u.
Homogeneous oxygen distribution and no viral infection
As a starting point, it is helpful to observe how
a tumour evolves in these environmental conditions without treatment, as shown in Fig. 2 for t = 1500 h (for the sake
of clarity, the ï¬gure represents the central section of the domain, i.e. the set [âˆ’L, L] Ã— {0}). The left panel shows the
total uninfected cell density U(t, x), which in absence of infection coincides with the total cancer density Ï(t, x); the
right panel shows the average epigenetic trait Âµ(t, x). Overall, we observe the behaviour predicted by the theoretical
asymptotic analysis in all the cases. The three initial conditions are given by Eq. (3.1) with y0 = Ï•(O). However, the
density Ï at the beginning is much lower than K; hence, unless we are in a normoxic situation, the ï¬ttest epigenetic trait
is lower than Ï•(O), as predicted by Eq. (2.11); on the other hand, in the normoxic situation Ï•(O) = 0 is already the
lowest attainable value. As time passes, the cell density grows close to carrying capacity and the cancer starts to invade
the surrounding area at a speed approximately proportional to the square root of the proliferation rate. In the hypoxic
scenarios, the ï¬ttest epigenetic trait grows with Ï until reaching the value Ï•(O); however, that trait is never completely
selected due to epigenetic diï¬€usion. An important consequence of the presence of diï¬€erent epigenetic characteristics is
the fact that Ï is always slightly below K, as the oxygen selection never completely stops: this eï¬€ect is especially evident
in the hypoxic situation, in which the slow proliferation contrasts the selective pressure less eï¬€ectively. It is important
to observe that in all cases the average epigenetic traits are lower at the invasion front, due to the lower total densities,
and increase as we get close to the tumour centre. Overall, high oxygen levels are associated with more proliferative
tumours, which reach carrying capacity earlier and invade the surrounding tissues faster.
9
Figure 3: Results of the numerical simulations for stationary oxygen at time tâˆ—, corresponding to approximately 1800 h
after viral injection, for three spatially homogeneous oxygen conditions: O = OM (solid lines, panel (a)), O = OM +Om
2
(dashed lines, panel (b)), and O = Om (dot-dashed lines, panel (c)). Only the horizontal section is shown to facilitate the
comparison. First column shows U(tâˆ—, x) in blue, I(tâˆ—, x) in red, and Ï(tâˆ—, x) in purple. The second column provides the
average epigenetic trait Âµ(tâˆ—, x) in green and Ï•(O(tâˆ—, x)) in light blue. The black lines show the theoretical approximation
of asymptotic equilibria, obtained by solving Eq. (2.12); in panel (c), Â¯y(tâˆ—, x) is not shown, as it is higher than 1.
10
Homogeneous oxygen distribution and virotherapy
From the previous discussion, it could appear that
hypoxic tumours do not constitute a signiï¬cant threat; however, this situation overturns in the presence of treatment,
as the adaptation to hypoxia makes the tumour less susceptible to therapies. Indeed, Fig.
3, along with the video
accompanying it (see electronic supplementary material S2), shows the eï¬€ect of oncolytic virotherapy on the tumours
described above. The diï¬€erent growth rates imply that the viral injection is performed at diï¬€erent times in the three
situations: this happens respectively around t = 426 h for normoxia, t = 471 h for physiological hypoxia and t = 609 h
for severe hypoxia. To facilitate the comparison between the diï¬€erent scenarios, Fig. 3 shows the section of the simulation
approximately 1800 h after the viral injection. In all three cases, the central region of the tumour is quickly infected and
viral particles are able to reach the tumour front in a relatively short time due to their fast diï¬€usion. In the severely
hypoxic case, this initial successful infection might appear surprising. Still, it can be easily explained by the fact that at
Tinj the tumour has not reached the carrying capacity yet and the epigenetic characteristics are still not fully adapted
to the environment (the lack of complete adaptation is also true in the other cases, but less evident).
The following dynamics appear quite diï¬€erent in the three cases. In the normoxic case (Fig. 3a), cell densities at
the centre of the tumour converge with damped oscillations to the equilibrium predicted by the theoretical analysis.
The average of the epigenetic traits in the central area sensibly increases right after the viral injection, then oscillates
towards the equilibrium. It is interesting to observe that epigenetic traits at the invasion front are lower since, in this
area, both Ï and I are lower; in other words, tumour invasion is guided by the most proliferative cells. The situation
is qualitatively similar in the physiologically hypoxic case (Fig. 3b), but the equilibrium value for U is higher. The
spatial diï¬€erence of the average epigenetic trait is much more evident than in the previous case: the convergence to the
equilibrium value is slower than before and takes place mainly from the lower side. While these two situations can be
described as partial successes of the therapy, the severely hypoxic case (Fig. 3c) is clearly a complete failure: the tumour
density decreases only for a short time, after which it starts to regrow up to around 90% of carrying capacity, with a
very small fraction of infected cells (not shown here, see electronic supplementary material S2); we remark that such a
low number of cells may model a situation of extinction due to stochastic events. After approximately 400 h, there is a
relapse of the infection, which causes a small decrease in the total cell density followed by a subsequent regrowth towards
the theoretical equilibrium. The convergence is extremely slow and it is clear from Fig. 3c that 1800 h after the viral
injection the dynamics are still far away from the equilibrium. This can be explained by the fact that the smaller growth
rate slows down all the evolutionary dynamics, hence it takes longer for the ï¬ttest trait to be selected. Furthermore, the
model is restricted to values y â‰¤1, hence the theoretical value Â¯y > 1 is unattainable; the convergence to 1 necessarily
takes place from below and this makes the uninfected population more susceptible to the infection. We remark that
longer numerical simulations conï¬rm the convergence towards 1 with the associated cell densities (not shown). However,
the equilibrium is reached only after a very long time, therefore from the application point of view we should note that
the treatment outcome is slightly better than expected (although still not successful).
Inhomogeneous oxygen distribution
We now increase the model complexity by considering spatial homo-
geneities of the oxygen. We consider the following oxygen spatial proï¬les:
1. O(x) = Om + (OM âˆ’Om)e
|x|2
20
(antigaussian);
2. O(x) = Om +
h1
2 + 1
Ï€ arctan
x1
2
i
(OM âˆ’Om) (step-like proï¬le).
The ï¬rst proï¬le is chosen to qualitatively resemble the oxygen distribution obtained after the tumourâ€™s consumption and
we expect to observe dynamics somehow similar to the ones described below when we drop the stationarity assump-
tion. The second one represents a tumour that grows at the boundary between two regions with signiï¬cantly diï¬€erent
vascularisation.
The numerical results of these two cases are shown in Fig. 4, along with the videos accompanying it (see electronic
supplementary materials S3 and S4),. We again represent the solutions approximately 1800 h after the viral injections,
which take place respectively at times t = 565 h and t = 470 h. The extremely slow growth in the ï¬rst situation is
due to the severely hypoxic conditions that characterise the initial growth: although this is probably unrealistic, later
dynamics appear comparable to biologically meaningful scenarios. In both cases, we observe behaviours coherent with the
previous ï¬ndings, with the invasion led by slightly more proliferative cells and the slower convergence to the theoretical
11
âˆ’10.0
âˆ’7.5
âˆ’5.0
âˆ’2.5
0.0
2.5
5.0
7.5
10.0
0.0
0.2
0.4
0.6
0.8
1.0
cell concentration [1/mm
3
]
Ã—10
6
(a) An(iga)ssian oxygen
Cell co)n(s
U
I
Ï
âˆ’10.0
âˆ’7.5
âˆ’5.0
âˆ’2.5
0.0
2.5
5.0
7.5
10.0
x
1
 [mm]
0.0
0.2
0.4
0.6
0.8
1.0
cell concen(ra(ion [1/mm
3
]
Ã—10
6
(b) S(ep-like oxygen
U
I
Ï
âˆ’10.0
âˆ’7.5
âˆ’5.0
âˆ’2.5
0.0
2.5
5.0
7.5
10.0
0.0
0.2
0.4
0.6
0.8
1.0
y
Epigenetic traits
Î¼
Ì„
y
Î¼
âˆ’10.0
âˆ’7.5
âˆ’5.0
âˆ’2.5
0.0
2.5
5.0
7.5
10.0
x
1
 [mm]
0.0
0.2
0.4
0.6
0.8
1.0
y
Î¼
Ì„
y
Î¼
Figure 4: Results of the numerical simulations for stationary oxygen with antigaussian and step-like proï¬les at time
tâˆ—corresponding to approximately 1800 h after viral injection. Only the horizontal section is shown to facilitate the
comparison with the equilibria. All the graphical elements have the same meaning as in Fig. 3.
12
âˆ’10
âˆ’5
0
5
10
âˆ’10.0
âˆ’7.5
âˆ’5.0
âˆ’2.5
0.0
2.5
5.0
7.5
10.0
U(t
*
,
x)
âˆ’10
âˆ’5
0
5
10
âˆ’10.0
âˆ’7.5
âˆ’5.0
âˆ’2.5
0.0
2.5
5.0
7.5
10.0
I(t
*
,
x)
âˆ’10
âˆ’5
0
5
10
âˆ’10.0
âˆ’7.5
âˆ’5.0
âˆ’2.5
0.0
2.5
5.0
7.5
10.0
Î¼(t
*
,
x)
âˆ’10
âˆ’5
0
5
10
âˆ’10.0
âˆ’7.5
âˆ’5.0
âˆ’2.5
0.0
2.5
5.0
7.5
10.0
Î¼(t
*
,
x)
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
Ã—10
6
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
Ã—10
6
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
0.000
0.171
0.342
0.513
0.684
0.855
1.026
1.197
1.368
1.539
1.710
Ã—10
âˆ’3
Figure 5: Results of the numerical simulations for stationary oxygen with step-like proï¬le at time tâˆ—corresponding to
approximately 1800 h after viral injection. We now show the densities in the whole domain to highlight the anisotropy.
The circle in the plot of U(tâˆ—, x) is centred in (0, 0) and the radius is the distance from the origin of the furthest point x
such that Ï(tâˆ—, x) > 0. On the other hand, the dark line in the plot of O(tâˆ—, x) encloses the region in which Ï(tâˆ—, x) > 0.
13
equilibrium in the hypoxic areas. The signiï¬cance of these situations is the emergence of new selective dynamics that
occur when the tumour reaches areas with diï¬€erent oxygen levels: in this respect, the eï¬€ectiveness of virotherapy diï¬€ers
signiï¬cantly from point to point.
Another signiï¬cant aspect is the nonsymmetrical conï¬guration of the step-like proï¬le, which allows to analyse the
inï¬‚uence of the oxygenation on the invasion speed. Fig. 5 shows the result of the simulation in the whole domain and it
is clear that the average epigenetic trait at the front signiï¬cantly diï¬€ers in the diï¬€erent directions. We recall that, in the
case of pressure-driven movement, the invasion speed is higher for high cell proliferation rate and high cell density. In
the case of our interest, fast proliferation is associated with eï¬€ective viral infection, which results in a lower cell density:
as a consequence, a priori, it is not trivial to understand which conditions are associated with a faster invasion. The
circle in Fig. 5 elucidates this aspect well, by showing that the fastest invasion still occurs in the most oxygenated area.
3.2
Inclusion of oxygen dynamics
In the previous section, we started with a basic model with homogeneous and stationary oxygenation, considering diï¬€erent
concentration levels; we subsequently included complexity in the model by considering spatial heterogeneity. We now
continue this progressive enrichment of the model toward realistic biological scenarios and consider the whole dynamics
of Eq. (2.9), in which oxygen varies both in space and time according to Eq. (2.8). A spatially heterogeneous oxygen
source allows us to consider vessels of diï¬€erent sizes and, thus, with variable blood ï¬‚ow.
We consider a source of the form
Q(x) = qO Â¯O(x)
where Â¯O(x) is the oxygen proï¬le that we would observe in the absence of the tumour. We remark that the actual oxygen
distribution is always below these values due to the increased oxygen consumption of cancer cells. We consider the
following oxygen proï¬les:
1. Â¯O(x) = OM (normoxia);
2. Â¯O(x) = 3 Om (hypoxia);
3. Â¯O(x) = 3 Om +
h1
2 + 1
Ï€ arctan
x1
2
i
(Omax âˆ’3 Om) (step-like source).
4. Â¯O(x) = 3 Om + (OM âˆ’3 Om)
3
X
k=1
eâˆ’|xâˆ’xk|2
15
with x1 := (âˆ’4, 4), x2 := (3, âˆ’6) and x3 := (6, âˆ’3) (source with three
peaks).
The homogeneous sources aim at reproducing uniformly vascularised tissues, which, in the absence of a tumour, are
either normoxic or physiologically hypoxic. The step-like source models a tissue with two distinguishable areas due to
diï¬€erent oxygen inï¬‚ow rates. Finally, the last source proï¬le constitutes an example of a tissue in which heterogeneous
vascularisation leads to a varied oxygen proï¬le.
We use as initial condition O0(x) the steady state of Eq. (2.8), i.e., the solution of the equation
DOâˆ†O(t, x) âˆ’qOO(t, x) âˆ’Î»Ï(0, x)O(t, x) + Q(x) = 0
where Ï(0, x) =
R
â„¦u0(x, y) dy and u0 is given in Eq. (3.1). We remark that our parameter choice allows to have the
same values of Ï(0, x) for all y0; as a consequence, it still makes sense to deï¬ne y0 = Ï•(O0(0)).
The results are collected in Figs.
6 and 7, along with the videos accompanying it (see electronic supplementary
materials S5, S6 and S7),. The arrangement of plots in Fig. 6 is analogous to Fig. 3, with the inclusion of Ï•(O(0, x)) in
the right panels: this allows to quantify the variation in time of the oxygen concentration due to tumour growth and the
consequent evolution of the trait selected by environmental conditions. Fig. 7 shows the simulation result in the whole
domain and highlights how the source heterogeneity aï¬€ects the dynamics.
In all four cases, the initial tumour growth causes a drop in oxygen concentration, reducing the environmentally
optimal epigenetic trait; consequently, the tumour growth progressively slows down. The variation of oxygen level is a
new selective pressure, which could not be considered in the stationary oxygen situation. The dynamics in the centre of
the tumour are characterized by a progressive adaptation, with the oxygen that reduces as the cell density grows and
14
âˆ’10.0
âˆ’7.5
âˆ’5.0
âˆ’2.5
0.0
2.5
5.0
7.5
10.0
0.0
0.2
0.4
0.6
0.8
1.0
cell concentration [1/mm
3
]
Ã—10
6
(a) No(moxia
Cell count)
U
I
Ï
âˆ’10.0
âˆ’7.5
âˆ’5.0
âˆ’2.5
0.0
2.5
5.0
7.5
10.0
0.0
0.2
0.4
0.6
0.8
1.0
cell concent(ation [1/mm
3
]
Ã—10
6
(b) P âˆ’).  âˆ’poxia
U
I
Ï
âˆ’10.0
âˆ’7.5
âˆ’5.0
âˆ’2.5
0.0
2.5
5.0
7.5
10.0
x
1
 [mm]
0.0
0.2
0.4
0.6
0.8
1.0
cell concent(ation [1/mm
3
]
Ã—10
6
(c) Step-like oxygen source
U
I
Ï
âˆ’10.0
âˆ’7.5
âˆ’5.0
âˆ’2.5
0.0
2.5
5.0
7.5
10.0
0.0
0.2
0.4
0.6
0.8
1.0
y
Epigenetic traits
Î¼
Ì„
y
Î¼
Î¼(O
0
)
âˆ’10.0
âˆ’7.5
âˆ’5.0
âˆ’2.5
0.0
2.5
5.0
7.5
10.0
0.0
0.2
0.4
0.6
0.8
1.0
y
Î¼
Ì„
y
Î¼
Î¼(O
0
)
âˆ’10.0
âˆ’7.5
âˆ’5.0
âˆ’2.5
0.0
2.5
5.0
7.5
10.0
x
1
 [mm]
0.0
0.2
0.4
0.6
0.8
1.0
y
Î¼
Ì„
y
Î¼
Î¼(O
0
)
Figure 6: Comparison of the results obtained from numerical simulation of the full model at time tâˆ—, corresponding to
approximately 1800 h after viral injection. Three spatial oxygen conditions are considered: normoxia (solid lines, panel
(a)), hypoxia (dashed lines, panel (b)), and step oxygen source (dot-dashed lines, panel (c)). For explicit formulation,
see the main text. All the graphical elements have the same meaning as in Fig. 3. In addition, a thinner light blue line
in the right panels provides the Ï• proï¬le at the initial state. The equilibria are now computed from Eq. (2.10).
15
the average epigenetic trait that increases as the oxygen density decreases. We remark that in this initial phase, the
actual ï¬ttest trait is always lower than the one selected by the environment due to the distance from carrying capacity;
as time passes, this diï¬€erence becomes less evident. In the meantime, the invasion fronts are more oxygenated, which
contributes to the selection of proliferative traits in this area; this behaviour resembles the dynamics observed in the
case of antigaussian stationary oxygen distribution. Spatial heterogeneity aï¬€ects the invasion in the cases of step-like
and multiple peak sources.
As with stationary oxygen, the viral injection constitutes an additional selective pressure. The virotherapy causes
a signiï¬cant decrease in the cancer population, which allows the reoxygenation of the tissue. Nevertheless, the initial
selective pressure of the infection appears more substantial than the environmental pressure, and the average epigenetic
trait signiï¬cantly increases.
As time passes, the infection is more eï¬€ective in the well-oxygenated areas: this keeps
the cancer population low and avoids an excessive reduction in the oxygen concentration, which would result in a less
eï¬€ective infection. Conversely, in the less oxygenated areas, the tumour grows up to close to carrying capacity; hence,
the oxygen concentration reduces further and the environmental conditions contribute to the selection of cells resistant
to the infection.
Fig. 6 shows that the solutions of the equation approach the theoretical estimates, but the convergence is slower
than in the case of stationary oxygen. This is particularly evident in the hypoxic areas due to the slow evolutionary
dynamics related to the low growth rate, as already observed for stationary oxygen, and it is now accentuated by the fact
that it takes time for the oxygen distribution to reach equilibrium. Furthermore, our tools do not allow to characterise
the wavefront, whose dynamics are signiï¬cantly far from equilibrium. Nevertheless, the theoretical values still provide
signiï¬cant information regarding the success of the therapy.
Overall, the main dynamics observed in Subsection 3.1 can be replicated without ï¬xing a priori the oxygen distribution
(which is not representative of realistic biological scenarios); oxygen dynamics signiï¬cantly enriches the evolutionary
dynamics. Initial condition referable as normoxic (panel (a)) or physiologically hypoxic (panel (b)) in the absence of the
tumour become respectively physiologically and severely hypoxic due to cancer: in this sense, these two settings can be
considered as a â€œtrait dâ€™unionâ€ with the previous simulations. Similar dynamics can also be observed in the presence of
more complex oxygen sources, such as the three-peaked source of Fig. 7: this suggests that the knowledge of the oxygen
distribution in a tumour may predict the outcome of the virotherapy in clinical settings.
3.3
Hypoxia-speciï¬c oncolytic viruses
All the simulations presented so far rely on the assumption that viral infection is less eï¬€ective in hypoxic cells: this can
be explained by their slower metabolic activity, which also aï¬€ects the translation of viral proteins [73]. Nevertheless, one
should note that some particular oncolytic viruses can speciï¬cally target receptors that are upregulated in case of the
lack of oxygen [71, 73]. This property appears particularly promising in light of the ineï¬€ectiveness of most classic cancer
therapies in hypoxic conditions [87].
Therefore, we revert the previous trade-oï¬€and exchange the values of Î²M and Î²m, so that the function Î²(y) is
increasing; the rest of the model remains unchanged. The asymptotic analysis of Appendix A does not rely on any
characterisation of the values of Î² and all the equations obtained are still valid: the only relevant diï¬€erence is the fact
that Eq. (2.11) now predicts a decrease of the ï¬ttest value in the presence of viral infection. The equilibrium values
depicted in Fig. 1b indeed shows that the virotherapyâ€™s eï¬€ectiveness increases as the oxygen concentration decreases, in
line with the biological situation we aim to model.
Fig. 8, along with the video accompanying it (see electronic supplementary material S8), shows the full model results
for the oxygen sources corresponding to normoxia and hypoxia. In the case of normoxia (Fig.
8a), we observe the
failure of the therapy: despite the persistence of the infection, the uninfected cell density is now approximately twice
the value observed in Fig. 6a; furthermore, the expansion of the tumour is much faster than in the case of virotherapy
with standard viruses that target non-hypoxic cells. Both these phenomena are caused by the fact that viral infection
selects cells with a value of the epigenetic trait lower than the one selected by environmental conditions alone, which
are both more proliferative and more resistant to the infection. Interestingly, the results are not trivial: indeed, a priori,
one could expect that the hypoxic condition caused by the tumour growth would be associated with a large number of
16
âˆ’10
âˆ’5
0
5
10
âˆ’10.0
âˆ’7.5
âˆ’5.0
âˆ’2.5
0.0
2.5
5.0
7.5
10.0
U(t
*
,
x)
âˆ’10
âˆ’5
0
5
10
âˆ’10.0
âˆ’7.5
âˆ’5.0
âˆ’2.5
0.0
2.5
5.0
7.5
10.0
I(t
*
,
x)
âˆ’10
âˆ’5
0
5
10
âˆ’10.0
âˆ’7.5
âˆ’5.0
âˆ’2.5
0.0
2.5
5.0
7.5
10.0
Î¼(t
*
,
x)
âˆ’10
âˆ’5
0
5
10
âˆ’10.0
âˆ’7.5
âˆ’5.0
âˆ’2.5
0.0
2.5
5.0
7.5
10.0
Î¼(t
*
,
x)
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
Ã—10
6
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
Ã—10
6
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
0.000
0.171
0.342
0.513
0.684
0.855
1.026
1.197
1.368
1.539
1.710
Ã—10
âˆ’3
Figure 7: Results of the numerical simulation for the full model with oxygen source with three peaks at time tâˆ—corre-
sponding to approximately 1800 h after viral injection. We now show the densities in the whole domain to highlight the
anisotropy. The dark line in the plot of O(tâˆ—, x) encloses the region in which Ï(tâˆ—, x) > 0.
17
âˆ’10.0
âˆ’7.5
âˆ’5.0
âˆ’2.5
0.0
2.5
5.0
7.5
10.0
0.0
0.2
0.4
0.6
0.8
1.0
cell concentration [1/mm
3
]
Ã—10
6
(a) Normo)ia
Ce   co(nts
U
I
Ï
âˆ’10.0
âˆ’7.5
âˆ’5.0
âˆ’2.5
0.0
2.5
5.0
7.5
10.0
x
1
 [mm]
0.0
0.2
0.4
0.6
0.8
1.0
ce   concentration [1/mm
3
]
Ã—10
6
(b) Phys. hypo)ia
U
I
Ï
âˆ’10.0
âˆ’7.5
âˆ’5.0
âˆ’2.5
0.0
2.5
5.0
7.5
10.0
0.0
0.2
0.4
0.6
0.8
1.0
y
Epigenetic traits
Î¼
Ì„
y
Î¼
âˆ’10.0
âˆ’7.5
âˆ’5.0
âˆ’2.5
0.0
2.5
5.0
7.5
10.0
x
1
 [mm]
0.0
0.2
0.4
0.6
0.8
1.0
y
Î¼
Ì„
y
Î¼
Figure 8: Comparison of the results obtained from numerical simulation of the full model in the case of hypoxia-targeting
oncolytic viruses at time tâˆ—, corresponding to approximately 1500 h after viral injection. We now consider an earlier
time than in the previous simulations, as the infection in this case promotes the selection of more proliferative cells and,
at later times, we would observe boundary eï¬€ects in the normoxic case. Two spatial oxygen conditions are considered:
normoxia (solid lines, panel (a)) and hypoxia (dashed lines, panel (b)); the oxygen sources are the same as in Figs. 6a-b.
All the graphical elements have the same meaning as in Fig. 3.
18
hypoxic cells, which are eï¬€ectively targeted by the virus. Our mathematical model is thus helpful to shed light on these
complex interactions.
The situation of physiological hypoxia appears much more promising (Fig. 8b). Again, we observe a decrease in
the average epigenetic trait caused by virotherapy, as expected from the theoretical results; consequently, the tumourâ€™s
invasion speed is also higher. Nevertheless, the cell lines selected are not too resistant to the infection and the tumour
cell density appears comparable to that observed in the case of normoxia treated by a standard virus. The important
consequence is that the eï¬€ectiveness of oncolytic virotherapy can be increased by selecting the most appropriate kind of
virus based on the oxygenation of the tumour.
The comparison between the two kinds of oncolytic viruses in the case of physiological hypoxia is further elucidated
in Fig. 9, in which we consider the total number of cancer cells in the domain
M(t) :=
Z
â„¦
Ï(t, x) dx
We also consider the evolution in time of the proportion of cells killed by environmental selection and the proportion of
tumour cells infected at a given instant, respectively
Î“S(t) :=
Î·
M(t)
Z
Y
Z
â„¦
(y âˆ’Ï•(O(t, x)))2u(t, x, y) dx dy,
Î“I(t) :=
1
M(t)
Z
Y
Z
â„¦
Î²(y)u(t, x, y)v(t, x) dx dy
In all cases, the main contribution to cell death is caused by viral infection, meaning that the therapy is always at least
partially eï¬€ective. The solid lines refer to the situation in which the oxygen concentration is not aï¬€ected by the tumour
and allow us to understand the role of oxygen dynamics; for the sake of brevity, this simulation is only performed in the
case Î²m < Î²M. The comparison with the analogous simulation of the full model (dashed lines) shows that more cells
are killed by environmental selection in the case of variable oxygen: indeed, hypoxia exerts a more signiï¬cant action
when the tumour needs to adapt to an evolving environment. The viral infection is more eï¬ƒcient in the latter case since
it takes a long time for the tumour to fully adapt to the hypoxic state and become resistant to the infection. When
the hypoxia-speciï¬c virus is considered, the infection appears signiï¬cantly more eï¬€ective. It is also remarkable that the
environmental selection is more relevant in the last situation: indeed, the value of Â¯y given by Eq. (2.11) is now much
lower than Ï•(O) (see again Figs. 6b and 8b), as for Î²M < Î²m both terms in the square bracket are negative; in other
words, the infection favours cells that are less resistant to hypoxia. We should therefore conclude that the therapeutic
eï¬€ectiveness is also due to environmental selection.
Although the use of hypoxia-selective oncolytic viruses appears promising, our ï¬ndings also stress that tumour erad-
ication is still far from achieved.
Furthermore, the cell lines selected are the most proliferative; hence, if the viral
infection stopped for some external reason (such as immune response), the tumour would quickly regain its aggressive-
ness. Nonetheless, it is essential to observe that the average epigenetic trait is signiï¬cantly reduced with respect to the
one that environmental conditions would select; consequently, the tumour is now sensitive to standard treatments that
lose their eï¬€ectiveness in hypoxic conditions. This suggests that a hypoxic tumour could be eï¬€ectively treated using a
combination of therapies targeting cells with diï¬€erent degrees of adaptation to hypoxia [73].
4
Conclusions
In this work, we have introduced a novel oncolytic virotherapy model that considers the epigenetic evolution of cancer
cells due to viral infection and hypoxia. By integrating viral dynamics, tumour evolution, and spatial oxygen gradi-
ents, our model provides new insights into how hypoxic conditions within tumours aï¬€ect the eï¬ƒcacy of oncolytic viral
therapies. Numerical simulations are coherent with the theoretical results obtained by a formal asymptotic analysis of
simpliï¬ed settings and show how environmental conditions inï¬‚uence the capability of the virus to control tumour mass
expansions and, in particular, underscore the signiï¬cant impact of oxygen availability on viral infection rates, tumour cell
susceptibility and the overall success of virotherapy. We have considered some simple conï¬gurations of oxygen sources to
capture the fundamental dynamics. Our results suggest that hypoxia may constitute a signiï¬cant obstacle to the success
of oncolytic virotherapy. Furthermore, the infection contributes to selecting a subpopulation of cells well adapted to
19
0
500
1000
1500
2000
2500
t [h]
0.0
0.2
0.4
0.6
0.8
1.0
cell co nt proportion
Ã—10
âˆ’1
stationary oxygen and Î²
m
<
Î²
M
dynamic oxygen and Î²
m
<
Î²
M
dynamic oxygen and Î²
m
>
Î²
M
0
500
1000
1500
2000
2500
t [h]
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
Ã—10
8
Î“
I
Î“
S
 , 
M
Figure 9: Comparison of the time evolution of the proportion of cells killed by environmental selection Î“I, the proportion
of tumour cells infected at a given instant Î“S and the total number of cancer cells M in the cases of stationary oxygen
and Î²m < Î²M (solid lines), dynamic oxygen and Î²m < Î²M (dashed lines), dynamic oxygen and Î²m > Î²M (dot-dashed
lines). In the case of stationary oxygen, the oxygen concentration is the equilibrium value of the corresponding model
with dynamic oxygen (as depicted in the right panel of Fig. 6b).
hypoxia, which may be hard to kill even with other therapies. Hypoxic tumours appear to be more eï¬€ectively treated
with oncolytic viruses speciï¬cally targeting hypoxic cells, although tumour eradication still appears hard to achieve.
Our ï¬ndings highlight several crucial aspects for optimising virotherapy: the presence of hypoxic regions can severely
limit the spread and replication of standard oncolytic viruses; in contrast, hypoxia-speciï¬c viruses are particularly
eï¬€ective in these areas. This suggests that therapeutic strategies need to account for spatial oxygen level variations.
The evolutionary dynamics of tumour cells under hypoxic stress and virotherapy pressure can lead to the emergence
of resistant phenotypes, indicating the need for adaptive treatment protocols that can mitigate resistance development.
One critical takeaway is the importance of considering the spatial heterogeneity of oxygen levels when designing and
implementing oncolytic virotherapy protocols. The model predicts that hypoxia can signiï¬cantly alter the distribution
and eï¬€ectiveness of viral therapy, thereby aï¬€ecting overall treatment outcomes. Additionally, the role of tumour cell
adaptations to hypoxic conditions highlights the necessity for dynamic treatment strategies that can respond to changes
in the tumour microenvironment.
The key assumption of this work is that, in general, the slower metabolic activity of hypoxic cells is associated with a
less eï¬€ective viral infection. This has been modelled by considering an infection rate Î² that depends on the adaptation of
cells to hypoxia. Our choice is motivated by the existing literature [52] and the possibility of obtaining some theoretical
insights. Other approaches would also be possible: for example, one may directly consider the dependence of viruses on
the host translational machinery to translate viral proteins; this would correspond to a viral burst size Î± that depends
on the oxygen concentration or on the level of metabolic activity of the cell (which could correspond to the variable y).
There are several promising directions for future research and the results may be extended in several ways, both
from the mathematical and the modeling perspectives. From the mathematical point of view, the formal asymptotic
analysis of Appendix A may constitute a good starting point for characterising the travelling waves shown in the
numerical simulations, at least in simpliï¬ed settings. From a biological point of view, we aim to develop a model to
study the interaction of oncolytic virotherapy and radiotherapy, which aligns with the clinical interest of combining the
two therapies. Radiotherapy is well-known to decrease its eï¬€ectiveness in hypoxic conditions and several mathematical
models similar to the one in the present work have been developed to investigate this phenomenon [16, 18]. Although
the combination with oncolytic viruses that decrease their eï¬ƒcacy due to hypoxia does not appear beneï¬cial, using
hypoxia-targeting oncolytic viruses could be promising.
Overall, our work contributes to a deeper understanding of the complexities of oncolytic virotherapy under hypoxic
conditions and lays the groundwork for developing more eï¬€ective and personalised cancer treatments. In this context,
mathematical models could help design the optimal combination, considering contemporary, subsequent, or alternating
20
treatments and investigating doses, orders and timing according to the environmental conditions.
A
Formal asymptotic analysis
We now conduct a formal asymptotic analysis to compute the theoretical equilibrium values, as explained in Section 2.2.
We introduce a small parameter Îµ and assume that
Dx = Îµ,
Dy = Dv = DO = Îµ2
In light of the time scaling t 7â†’t
Îµ, we deï¬ne
uÎµ(t, x, y) := u
 t
Îµ, x, y

,
IÎµ(t, x) := I
 t
Îµ, x

,
vÎµ(t, x) := v
 t
Îµ, x

,
OÎµ(t, x) := O
 t
Îµ, x

The system of Eq. (2.9) then becomes
ï£±
ï£´
ï£´
ï£´
ï£´
ï£´
ï£´
ï£´
ï£´
ï£²
ï£´
ï£´
ï£´
ï£´
ï£´
ï£´
ï£´
ï£´
ï£³
Îµâˆ‚tuÎµ(t, x, y) = Îµ2âˆ‚2
yyuÎµ(t, x, y) + Îµ divx(uÎµ(t, x, y)âˆ‡ÏÎµ(t, x))
+ R(y, ÏÎµ(t, x), OÎµ(t, x), vÎµ(t, x)) uÎµ(t, x, y)
Îµâˆ‚tIÎµ(t, x) = Îµ div(IÎµ(t, x)âˆ‡ÏÎµ(t, x)) + vÎµ(t, x)
R
Y Î²(y)u(t, x, y) dy âˆ’qII(t, x)
Îµâˆ‚tvÎµ(t, x) = Îµ2âˆ†vÎµ(t, x) + Î±qIIÎµ(t, x) âˆ’qvvÎµ(t, x)
âˆ‚tOÎµ(t, x) = Îµ2âˆ†OÎµ(t, x) âˆ’qOOÎµ(t, x) âˆ’Î»Ï(t, x)OÎµ(t, x) + Q(x)
ÏÎµ(t, x) :=
R
Y uÎµ(t, x, y) dy + IÎµ(t, x)
(A.1)
Let us observe that, letting Îµ â†’0 and assuming that all the functions converge, we immediately get from the third
equation that
v(t, x) = Î±qI
qv I(t, x)
(A.2)
and from the second equation that
I(t, x) = 0
or
Z
Y
Î²(y)u(t, x, y) dy = qII(t, x)
v(t, x)
= qv
Î±
(A.3)
Furthermore, the fourth equation yields
O(t, x) =
Q(x)
qO + Î»Ï(t, x)
(A.4)
and, for simplicity, we assume that the oxygen source is spatially homogeneous so that Q(t, x) â‰¡Q. It is important to
note that the system may not converge to an equilibrium: indeed, for some parameter values, central oscillations persist
even for very long times, similar to the ones described in Refs. [9, 67] (see also electronic supplementary material S9).
We then make for uninfected cells the real phase WKB ansatz [10, 25, 27], as it is common in the Hamiltonâ€“Jacobi
approach presented, for example, in [22, 54, 63, 64]
uÎµ(t, x, y) = e
nÎµ(t,x,y)
Îµ
This implies
âˆ‚tuÎµ = âˆ‚tnÎµ
Îµ
uÎµ,
âˆ‡xuÎµ = âˆ‡xnÎµ
Îµ
uÎµ,
âˆ‚2
yyuÎµ =
(âˆ‚ynÎµ)2
Îµ2
+ âˆ‚2
yynÎµ
Îµ

uÎµ
The ï¬rst equation of Eq. (A.1) yields
âˆ‚tnÎµ = (âˆ‚ynÎµ)2 + Îµâˆ‚2
yynÎµ + âˆ‡xnÎµ Â· âˆ‡ÏÎµ(t, x) + Îµâˆ†ÏÎµ(t, x) + R(y, ÏÎµ(t, x), OÎµ(t, x), vÎµ(t, x))
Letting Îµ â†’0 and assuming convergence, we obtain
âˆ‚tn = (âˆ‚yn)2 + âˆ‡xn Â· âˆ‡Ï(t, x) + R(y, Ï(t, x), O(t, x), v(t, x))
(A.5)
21
All the functions without the subscript Îµ are the leading order terms of the asymptotic expansion.
Under appropriate concavity hypotheses, we expect n to be a strictly concave function of y; we deï¬ne
Â¯y(t, x) := arg max
yâˆˆY n(t, x, y)
Let us ï¬x x âˆˆsupp(Ï). The fact that ÏÎµ(t, x) < +âˆfor all Îµ implies that
n(t, x, Â¯y(t, x)) = max
yâˆˆY n(t, x, y) = 0
and therefore trivially
âˆ‚yn(t, x, Â¯y(t, x)) = 0
We also observe that
0 = âˆ‚
âˆ‚tn(t, x, Â¯y(t, x)) = âˆ‚tn(t, x, y)|y=Â¯y(t,x) + âˆ‚yn(t, x, y)|y=Â¯y(t,x)âˆ‚tÂ¯y(t, x)
implying that âˆ‚tn(t, x, Â¯y(t, x)) = 0; similarly, âˆ‡xn(t, x, Â¯y(t, x)) = 0.
We evaluate Eq. (A.5) in y = Â¯y(t, x) to get
[pM + (pm âˆ’pM)y]

1 âˆ’Ï
K

âˆ’Î·(y âˆ’Ï•(O(t, x)))2 âˆ’[Î²M + (Î²m âˆ’Î²M)y]v =
= R(Â¯y(t, x), Ï(t, x), O(t, x), v(t, x)) = âˆ‚tn âˆ’(âˆ‚yn)2 âˆ’âˆ‡xn Â· âˆ‡Ï(t, x) = 0
(A.6)
We can also diï¬€erentiate Eq. (A.5) with respect to y to get
âˆ‚2
tyn = 2âˆ‚yn âˆ‚2
yyn + âˆ‚yâˆ‡xn Â· âˆ‡Ï(t, x) + âˆ‡xn Â· âˆ‚yâˆ‡Ï(t, x) + âˆ‚yR(y, Ï(t, x), O(t, x), v(t, x))
which computed at y = Â¯y(t, x) yields
âˆ‚2
tyn(t, x, Â¯y(t, x)) = âˆ‚yâˆ‡xn(t, x, Â¯y(t, x)) Â· âˆ‡Ï(t, x) + âˆ‚yR(Â¯y(t, x), Ï(t, x), O(t, x), v(t, x))
If we look for a homogeneous steady state, then the previous equation implies
âˆ‚yR(Â¯y, Ï, O, v) = (pm âˆ’pM)

1 âˆ’Ï
K

âˆ’2Î·(y âˆ’Ï•(O)) âˆ’(Î²m âˆ’Î²M)v = 0
(A.7)
It is reasonable to consider uÎµ
âˆ—â‡€Ë†u Î´Â¯y, in the meaning of weak-âˆ—convergence of measures, i.e.
Z
Y
Ïˆ(y)uÎµ(t, x, y)
Îµâ†’0
âˆ’âˆ’âˆ’â†’Ïˆ(Â¯y)Ë†u(t, x)
âˆ€Ïˆ âˆˆC0(Y )
Therefore,
Z
Y
Î²(y)uÎµ(t, x, y) dy â†’Î²(Â¯y) Â¯U
where the bar over the U is used to refer to the equilibrium value. With this observation, Eqs. (A.2), (A.3), (A.4), (A.6)
and (A.7) constitute a system of ï¬ve equations in the ï¬ve variables Â¯U, Â¯I, Â¯v, Â¯O, Â¯y, which in principle can be solved.
Let us ï¬rst focus on the infection-free case of Eq. (A.3), i.e. Â¯I = 0. This clearly implies Â¯v = 0 and the other three
variables solve the system
ï£±
ï£´
ï£´
ï£´
ï£´
ï£´
ï£´
ï£´
ï£²
ï£´
ï£´
ï£´
ï£´
ï£´
ï£´
ï£´
ï£³
R(Â¯y, Â¯U, Â¯O, 0) = p(Â¯y)

1 âˆ’
Â¯U
K

âˆ’Î·(Â¯y âˆ’Ï•( Â¯O))2 = 0
âˆ‚yR(Â¯y, Â¯U, Â¯O, 0) = (pm âˆ’pM)

1 âˆ’
Â¯U
K

âˆ’2Î·(Â¯y âˆ’Ï•( Â¯O)) = 0
Â¯O =
Q
qO + Î» Â¯U
(A.8)
22
From the ï¬rst two equations, we obtain
1 âˆ’
Â¯U
K = Î·(y âˆ’Ï•( Â¯O))2
p(Â¯y)
= 2Î·(y âˆ’Ï•( Â¯O))
(pm âˆ’pM)
which admits two solutions: the ï¬rst one is Â¯U = K, Â¯y = Ï•( Â¯O); the second one is
Â¯y =
2pM
pM âˆ’pm âˆ’Ï•( Â¯O) >
2pM
pM âˆ’pm âˆ’1 = pM + pm
pM âˆ’pm > 1
Â¯U = K + 4Î·p(Ï•( Â¯O))
(pm âˆ’pM)2 > K
but it clearly has no biological meaning. If we assume that the oxygen concentration is not aï¬€ected by tumour dynamics,
then we neglect the third equation of Eq. (A.8) and the equilibria are the above ones. If we consider the full system,
then the ï¬rst equilibrium is given by
Â¯U = K,
Â¯O =
Q
qO + Î»K ,
Â¯y = Ï•( Â¯O)
The second equilibrium could be obtained by computing the solutions of a second-degree equation in Â¯O; given the
complexity of the expressions and the lack of biological meaning, we omit further details.
Let us now assume Â¯I Ì¸= 0, which according to Eq. (A.3) implies
Â¯U =
qv
Î±Î²(Â¯y)
This leads to the system of Eq. (2.10), described in the main text.
B
Details of numerical simulations
B.1
Parameter values
Table 1 lists the parameters we adopt as a reference in the numerical simulations.
The majority of the parameters
has been estimated from the empirical literature, while a few others are speciï¬c to our formulation of the model and
have been set to reasonable values in order to reproduce plausible dynamics. Our two-dimensional simulations represent
the section of a tumour that is approximately homogeneous along the third spatial dimension (which can therefore be
neglected) and parameters are estimated in a three-dimensional setting.
The maximal duplication rate of uninfected cells pM, corresponding to the normoxic situation, has been taken equal
to log(2)/24 hâˆ’1 â‰ˆ2.88 Ã— 10âˆ’2 hâˆ’1; the duplication time of 24 hours is among the fastest values reported in Ref. [42]
for glioblastoma. On the other hand, we assume that severely hypoxic cells duplicate in 48 hours, as done in Ref. [55]:
this leads to a minimal proliferation rate pm = 1.44 Ã— 10âˆ’2 hâˆ’1. The carrying capacity K has been estimated assuming
that a cell has diameter 10 Âµm= 10âˆ’2 mm [48, Â§1.1]: this implies that the carrying capacity is 106 cells/mm3.
The spatial diï¬€usion coeï¬ƒcient of tumour cells Dx has been estimated from the experimental data of the U343 control
group of [44], as already done in Refs. [58, 67]. In these experiments, the tumour volume passes in 40 days from 70 mm3
to 1000 mm3, which corresponds to a change in the tumour radius from approximately 2.6 mm to approximately 6.2 mm.
Hypoxia may play some role in the process, but this is not taken into account in their data: for the sake of simplicity,
we assume a moderately hypoxic situation so that the proliferation rate takes the value p(0.5) (i.e., the average between
pM and pm). Hence, the dynamics of uninfected cells in the absence of viral infection follow the equation
âˆ‚tu(t, x) = Dx divx(u(t, x)âˆ‡u(t, x)) + p(0.5)

1 âˆ’u(t, x)
K

u(t, x)
23
As we mention in the main text, an initial condition with compact support evolves into a wave that travels with the
minimal speed
p
DxKp(0.5)/2 [7, 60]; this yields the estimate
Dx = 2c2
Kp =
6.2 âˆ’2.6 mm
40 Ã— 24 h
2
Ã—
2
106 Ã— cells/mm3 Ã— 2.16 Ã— 10âˆ’2 hâˆ’1
â‰ˆ1.30 Ã— 10âˆ’3 mm2/h
106 Ã— cells/mm3
â‰ˆ1.30 Ã— 10âˆ’9 (mm Ã— cells Ã— h)âˆ’1
We assume that this coeï¬ƒcient is the same also for infected cells, as a priori we have no reason to believe that the
infection aï¬€ects cellular movement.
The death rate of uninfected tumour cells due to oxygen-driven selection Î· and the epigenetic diï¬€usion coeï¬ƒcient
of tumour cells Dy are not easily accessible in the empirical literature, hence they have been adapted from previous
mathematical papers about epigenetically structured populations: their values have been set respectively to 1/48 hâˆ’1 â‰ˆ
4.16 Ã— 10âˆ’2 hâˆ’1, which is of the same magnitude of the value used in Ref. [19], and 5.00 Ã— 10âˆ’6 hâˆ’1, as in Ref. [16].
The maximal infection rate of the oncolytic virus Î²M has been set to 7.00 Ã— 10âˆ’10 mm3/(virusesÃ—h), as in Ref. [31];
their model does not explicitly take into account hypoxia, so we assume that they consider normoxic conditions. Since
we are not aware of any experimental estimate of infection rate under hypoxic conditions, we set Î²m to one fourth of
the value of Î²m. The death rate of infected cells qI has been taken equal to 1/24 hâˆ’1 = 4.17 Ã— 10âˆ’2 hâˆ’1, following Ref.
[33]. The clearance rate of the virus has been set to 1/6, as in Ref. [57]. The viral load released by the death of infected
cells depends highly on the type of virus and ranges from the value 157 viruses/cells estimated in Ref. [84] to the value
3500 viruses/cells of Ref. [17]; we chose an intermediate value of Î± = 1000 viruses/cells. It is important to remark that
all these values are highly dependent on the exact type of oncolytic virus employed; our choices allow to model signiï¬cant
diï¬€erences in the eï¬€ectiveness of oncolytic virotherapy as the oxygen level varies. We remark that the outcome of the
therapy is mostly determined by the aggregate value Î²Î±qI/qv, hence similar dynamics may also be obtained by diï¬€erent
parameter combinations that maintain the ratio unchanged (see also the discussion in Ref. [58]). The spatial diï¬€usion
coeï¬ƒcient of viral particles Dv has been set to 3.6 Ã— 10âˆ’2 mm2/h, as in Ref. [31].
We consider the oxygen thresholds deï¬ned in Ref. [56]: the oxygen partial pressure (pO2) in arterial blood is 70 mmHg
and we consider this as the maximal oxygen concentration (Omax); the physiological pO2 ranges approximately between
57 mmHg and 30.4 mmHg, so we consider the higher value as the normoxic threshold OM, keeping in mind that we
may observe lower oxygen values also in healthy tissue; the pathological hypoxic pO2 value is 7.6 mmHg, which we
consider as Om. All these pressure values are converted in volume ratios by multiplying them by the solubility constant
3 Â· 10âˆ’5 mm3
O2/(mm3
plasmaÃ—mmHg) [65].
We assume that the oxygen decay is due to the consumption of the healthy cells in the region. According to [80],
cells have an average rate of oxygen utilisation of 9.00 Ã— 10âˆ’15 mol/(cellÃ—h), corresponding approximately to 2.02 Ã—
10âˆ’7 mmO2/(cellsÃ—h), but this value may vary several orders of magnitude among diï¬€erent cell types. We therefore
assume that a single healthy cell consumes six times this amount of oxygen when the available oxygen level is at Omax
and the consumption scales linearly with the oxygen concentration, meaning that the consumption in the case of unitary
cell density is given by O(t, x) multiplied by
1.21 Ã— 10âˆ’6 mm3
O2
cell Ã— h
1
Omax = 5.60 Ã— 10âˆ’4 mm3/(cell Ã— h)
Considering K as the healthy cell density in the absence of a tumour, we obtain a decay rate qO = 5.60 Ã— 102 hâˆ’1.
We adopt a similar way of reasoning for the consumption by cancer cells, starting from the fact that the consumption
of a single cell is estimated to be 2.62 Ã— 10âˆ’6 mmO2/(cellsÃ—h) [35] and assuming again that this is only possible when
the oxygen level is Omax. We then assume that cancer cells take the place of healthy cells, meaning that they cause an
additional consumption of
Î» = 2.62 Ã— 10âˆ’6mmO2/(cells Ã— h)
Omax
âˆ’qO
K = 6.55 Ã— 10âˆ’4 mm3/(cell Ã— h)
The oxygen diï¬€usion coeï¬ƒcient DO has been set to 3.60 mm2/h, as in Ref. [59].
24
Numerical simulations are run until the ï¬nal time T = 2500 h, since their behaviour up to that moment is also
representative of later dynamics. For the spatial domain â„¦= [âˆ’L, L]2 , we set L = 10 mm so that in most cases wave
fronts do not hit the boundary before T and the domain is representative of typical extensions of solid tumours.
B.2
Numerical method
Numerical simulations use a ï¬nite volume method developed by adapting the procedures presented in Refs. [12, 15] to
our problem. We discretise the space â„¦with a uniform mesh consisting of the cells
Cj,k := [x1,jâˆ’1
2 , x1,j+ 1
2 ] Ã— [x2,kâˆ’1
2 , x2,k+ 1
2 ]
for j = 0, . . . , Nx1, k = 0, . . . , Nx2. Similarly, we discretise the space â„¦Ã— Y with the cells
Cj,k,m := [x1,jâˆ’1
2 , x1,j+ 1
2 ] Ã— [x2,kâˆ’1
2 , x2,k+ 1
2 ] Ã— [ymâˆ’1
2 , ym+ 1
2 ]
for j = 0, . . . , Nx1, k = 0, . . . , Nx2, and m = 0, . . . , Ny.
The sizes of the cells are thus respectively âˆ†x1 Ã— âˆ†x2 and
âˆ†x1 Ã— âˆ†x2 Ã— âˆ†y, where
âˆ†xi =
2L
Nxi + 1
(i = 1, 2)
âˆ†y =
1
Ny + 1
We set Nxi = 200 and Ny = 20.
The equations for infected cells, viruses and oxygen are not epigenetically structured and are of the form
âˆ‚tf(t, x) = M(t, x) + R(t, x)
where M(t, x) regulates the movement and R(t, x) the reactions. We adopt a splitting method, considering separately
the movement and reaction terms. The quantity of our interest is
fj,k(t) =
1
âˆ†x1âˆ†x2
Z
Cj,k
f(t, x) dx
We begin with the conservative part M(t, x), which is given by
M(t, x) = Dâˆ†xf = D divx(âˆ‡xf)
in the case of virus and oxygen and by
M(t, x) = D divx(Î¦(t, x)f),
Î¦(t, x) = âˆ‡xÏ(t, x)
in the case of infected cells. In both situations, M involves the divergence of some quantity, hence the semi-discrete
scheme takes the form
df
dt = âˆ’D
Mj+ 1
2 ,k(t) âˆ’Mjâˆ’1
2 ,k(t)
âˆ†x1
âˆ’D
Mj,k+ 1
2 (t) âˆ’Mj,kâˆ’1
2 (t)
âˆ†x2
(B.1)
where M is given by
Mj+ 1
2 ,k = âˆ’âˆ‚x1fj+ 1
2 ,k
Mj,k+ 1
2 = âˆ’âˆ‚x2fj,k+ 1
2
in the case of spatial diï¬€usion and by
Mj+ 1
2 ,k = (Î¦1
j+ 1
2 ,k)+fj,k + (Î¦1
j+ 1
2 ,k)âˆ’fj+1,k
Mj,k+ 1
2 = (Î¦2
j,k+ 1
2 )+fj,k + (Î¦2
j,k+ 1
2 )âˆ’fj,k+1
in the case of pressure-driven movement. In this second case, Î¦1 := âˆ‚x1Î¦ and Î¦2 := âˆ‚x2Î¦ are the components of Î¦
along the x1 and x2 axis respectively; furthermore, (Â·)+ and (Â·)âˆ’indicate respectively the positive and negative part of
their arguments, i.e., (Â·)+ = max{0, Â·} and (Â·)âˆ’= min{0, Â·}. Since our scheme is of order zero, the reconstruction of the
function is piecewise constant and thus assumes the same values at all the interfaces. In all the cases, the derivatives in
the middle points are evaluated as
(âˆ‚x1f)j+ 1
2 ,k = fj+1,k âˆ’fj,k
âˆ†x1
,
(âˆ‚x2f)j,k+ 1
2 = fj,k+1 âˆ’fj,k
âˆ†x2
25
while the derivatives in the nodes are evaluated as
(âˆ‚x1f)j,k = fj+1,k âˆ’fjâˆ’1,k
2âˆ†x1
,
(âˆ‚x2f)j,k = fj,k+1 âˆ’fj,kâˆ’1
2âˆ†x2
We use a uniform time discretisation of size âˆ†t = 5 Ã— 10âˆ’1 h and denote with apex l the discretised time step, i.e.,
tl = lâˆ†t. At all the iterations, we check that âˆ†t satisï¬es the positivity-preserving CFL for infected cells, namely
âˆ†t â‰¤âˆ†Tl := min
 âˆ†x1
4Î¦1
M
, âˆ†x2
4Î¦2
M

where Î¦1
M = max
j,k

|Î¦1 l
j+ 1
2 ,k|

and Î¦2
M = max
j,k

|Î¦2 l
j,k+ 1
2 |

. In the case of standard diï¬€usion, the CFL is time-independent
and is given by
âˆ†t â‰¤min
(âˆ†x1)2
4D
, (âˆ†x2)2
4D

The fast oxygen dynamics require a reï¬ned temporal discretisation. Hence, we set âˆ†tO = 6.95Ã—10âˆ’5 (which is one-tenth
of the maximum size required by the CFL condition for oxygen) and perform several sub-iterations just for the oxygen
while maintaining all the other quantities constant.
For the reaction term R(t, x), we adopt a simple forward Euler method for the time derivative. We set the discretised
initial condition f 0
j,k provided for each j = 0, . . . , Nx1 and for k = 0, . . . , Nx2, being f l
j,k the numerical approximation of
fj,k(tl). The complete splitted numerical scheme reads
ï£±
ï£´
ï£´
ï£²
ï£´
ï£´
ï£³
f
l+ 1
2
j,k
= f l
j,k âˆ’D âˆ†t
âˆ†x1

M l
j+ 1
2 ,k âˆ’M l
jâˆ’1
2 ,k

âˆ’D âˆ†t
âˆ†x2

M l
j,k+ 1
2 âˆ’M l
j,kâˆ’1
2

f l+1
j,k = f
l+ 1
2
j,k
+ âˆ†t R
l+ 1
2
j,k
for l = 1, . . . , Nl. We also set no ï¬‚ux boundary conditions.
The equation for uninfected cells is epigenetically structured and takes the form
âˆ‚f
âˆ‚t (t, x, y) = M(t, x, y) + R(t, x, y)
where
M(t, x, y) = Dx divx(Î¦(t, x)f) + Dyâˆ†yf
Therefore, we are now interested in the quantity
fj,k(t) =
1
âˆ†x1âˆ†x2âˆ†y
Z
Cj,k,m
f(t, x, y) dx dy
The semi-discrete scheme of the equation takes a form analogous to Eq. (B.1), which requires the following deï¬nitions:
Mj+ 1
2 ,k,m = (Î¦1
j+ 1
2 ,k,m)+fj,k,m + (Î¦1
j+ 1
2 ,k,m)âˆ’fj+1,k,m
Mj,k+ 1
2 ,m = (Î¦2
j,k+ 1
2 ,m)+fj,k,m + (Î¦2
j,k+ 1
2 ,m)âˆ’fj,k+1,m
Nj,k,m+ 1
2 = âˆ’âˆ‚yfj,k,m+ 1
2
The corresponding splitted numerical scheme is
ï£±
ï£´
ï£´
ï£´
ï£´
ï£´
ï£²
ï£´
ï£´
ï£´
ï£´
ï£´
ï£³
f
l+ 1
3
j,k,m = f l
j,k,m âˆ’âˆ†t
âˆ†x1

M l
j+ 1
2 ,k,m âˆ’M l
jâˆ’1
2 ,k,m

âˆ’âˆ†t
âˆ†x2

M l
j,k+ 1
2 ,m âˆ’M l
j,kâˆ’1
2 ,m

f
l+ 2
3
j,k,m = f
l+ 1
3
j,k,m âˆ’âˆ†t
âˆ†y

N
l+ 1
3
j,k,m+ 1
2 âˆ’N
l+ 1
3
j,k,mâˆ’1
2

f l+1
j,k,m = f
l+ 2
3
j,k,m + âˆ†t R
l+ 2
3
j,k,m
26
References
[1] L. Almeida, P.-A. Bliman, G. Nadin, B. Perthame, and N. Vauchelet, Final size and convergence rate
for an epidemic in heterogeneous populations, Mathematical Models and Methods in Applied Sciences, 31 (2021),
pp. 1021â€“1051.
[2] N. Almuallem, D. Trucu, and R. Eftimie, Oncolytic viral therapies and the delicate balance between virus-
macrophage-tumour interactions: A mathematical approach, Mathematical Biosciences and Engineering, 18 (2021),
pp. 764â€“799.
[3] T. Alzahrani, R. Eftimie, and D. Trucu, Multiscale modelling of cancer response to oncolytic viral therapy,
Mathematical Biosciences, 310 (2019), pp. 76â€“95.
[4] A. ArdaË‡seva, A. R. A. Anderson, R. A. Gatenby, H. M. Byrne, P. K. Maini, and T. Lorenzi, Comparative
study between discrete and continuum models for the evolution of competing phenotype-structured cell populations in
dynamical environments, Physical Review E, 102 (2020).
[5] A. ArdaË‡seva, R. A. Gatenby, A. R. Anderson, H. M. Byrne, P. K. Maini, and T. Lorenzi, A mathematical
dissection of the adaptation of cell populations to ï¬‚uctuating oxygen levels, Bulletin of Mathematical Biology, 82
(2020), pp. 1â€“24.
[6] A. ArdaË‡seva, R. A. Gatenby, A. R. A. Anderson, H. M. Byrne, P. K. Maini, and T. Lorenzi, Evolu-
tionary dynamics of competing phenotype-structured populations in periodically ï¬‚uctuating environments, Journal of
Mathematical Biology, 80 (2020), pp. 775â€“807.
[7] D. G. Aronson, Density-dependent interactionâ€“diï¬€usion systems, in Dynamics and Modelling of Reactive Systems,
W. E. STEWART, W. H. RAY, and C. C. CONLEY, eds., Academic Press, 1980, pp. 161â€“176.
[8] S. Astanin and L. Preziosi, Multiphase models of tumour growth, in Selected topics in cancer modeling, Springer,
2008, pp. 1â€“31.
[9] A. A. Baabdulla and T. Hillen, Oscillations in a spatial oncolytic virus model, Bulletin of Mathematical Biology,
86 (2024).
[10] G. Barles, L. Evans, and P. Sougandis, Wavefront propagation for reaction-diï¬€usion systems of pde, Duke
Mathematical Journal, 61 (1990), pp. 835â€“858.
[11] E. Bernardi, L. Pareschi, G. Toscani, and M. Zanella, Eï¬€ects of vaccination eï¬ƒcacy on wealth distribution
in kinetic epidemic models, Entropy, 24 (2022).
[12] M. Bessemoulin-Chatard and F. Filbet, A ï¬nite volume scheme for nonlinear degenerate parabolic equations,
SIAM Journal on Scientiï¬c Computing, 34 (2012), pp. B559â€“B583.
[13] P. Blanchette and J. G. Teodoro, A renaissance for oncolytic adenoviruses?, Viruses, 15 (2023).
[14] M. A. Boemo and H. M. Byrne, Mathematical modelling of a hypoxia-regulated oncolytic virus delivered by
tumour-associated macrophages, Journal of Theoretical Biology, 461 (2019), pp. 102â€“116.
[15] J. A. Carrillo, A. Chertock, and Y. Huang, A ï¬nite-volume method for nonlinear nonlocal equations with a
gradient ï¬‚ow structure, Communications in computational physics, 17 (2015).
[16] G. L. Celora, H. M. Byrne, C. E. Zois, and P. Kevrekidis, Phenotypic variation modulates the growth
dynamics and response to radiotherapy of solid tumours under normoxia and hypoxia, Journal of Theoretical Biology,
527 (2021).
[17] Y. Chen, T. DeWeese, J. Dilley, Y. Zhang, Y. Li, N. Ramesh, J. Lee, R. Pennathur-Das, J. Radzyminski,
J. Wypych, et al., CV706, a prostate cancer-speciï¬c adenovirus variant, in combination with radiotherapy produces
synergistic antitumor eï¬ƒcacy without increasing toxicity, Cancer Research, 61 (2001), pp. 5453â€“5460.
[18] G. Chiari, G. Fiandaca, and M. E. Delitala, Hypoxia-related radiotherapy resistance in tumors: treatment
eï¬ƒcacy investigation in an eco-evolutionary perspective, Frontiers in Applied Mathematics and Statistics, 9 (2023).
[19]
, Hypoxia-resistance heterogeneity in tumours: the impact of geometrical characterization of environmental
niches and evolutionary trade-oï¬€s. a mathematical approach, Mathematical Modelling of Natural Phenomena, 18
(2023).
27
[20] A. L. de Araujo, A. C. Fassoni, K. F. Madalena, and L. F. Salvino, Analysis and simulation of an integro-
diï¬€erential lotkaâ€“volterra model with variable reproduction rates and optimal control, Communications in Nonlinear
Science and Numerical Simulation, 134 (2024), p. 108000.
[21] M. Delitala and T. Lorenzi, Evolutionary branching patterns in predator-prey structured populations, Discrete
and Continuous Dynamical Systems - Series B, 18 (2013), pp. 2267â€“2282.
[22] O. Diekmann, P.-E. Jabin, S. Mischler, and B. Perthame, The dynamics of adaptation: An illuminating
example and a hamilton-jacobi approach, Theoretical Population Biology, 67 (2005), pp. 257â€“271.
[23] C. Ding, Z. Wang, and Q. Zhang, Age-structure model for oncolytic virotherapy, International Journal of Biomath-
ematics, 15 (2022), p. 2150091.
[24] R. Eftimie and G. Eftimie, Tumour-associated macrophages and oncolytic virotherapies: A mathematical inves-
tigation into a complex dynamics, Letters in Biomathematics, 5 (2018), pp. pp. S6â€“S35.
[25] L. C. Evans and P. E. Souganidis, A Â´e approach to geometric optics for certain semilinear parabolic equations,
Indiana University Mathematics Journal, 38 (1989), pp. 141â€“172.
[26] G. Fiandaca, M. Delitala, and T. Lorenzi, A mathematical study of the inï¬‚uence of hypoxia and acidity on
the evolutionary dynamics of cancer, Bulletin of mathematical biology, 83 (2021), pp. 1â€“29.
[27] W. H. Fleming and P. E. Souganidis, Pde-viscosity solution approach to some problems of large deviations,
Annali Della Scuola Normale Superiore Di Pisa-classe Di Scienze, 13 (1986), pp. 171â€“192.
[28] C. Fountzilas, S. Patel, and D. Mahalingam, Review: Oncolytic virotherapy, updates and future directions,
Oncotarget, 8 (2017), pp. 102617â€“102639.
[29] A. Friedman and X. Lai, Combination therapy for cancer with oncolytic virus and checkpoint inhibitor: A math-
ematical model, PloS one, 13 (2018), pp. 1â€“21.
[30] A. Friedman and Y. Tao, Analysis of a model of a virus that replicates selectively in tumor cells, Journal of
Mathematical Biology, 47 (2003), pp. 391â€“423.
[31] A. Friedman, J. P. Tian, G. Fulci, E. A. Chiocca, and J. Wang, Glioma virotherapy: Eï¬€ects of innate
immune suppression and increased viral replication capacity, Cancer Research, 66 (2006), pp. 2314â€“2319.
[32] J. A. Gallaher, J. S. Brown, and A. R. A. Anderson, The impact of proliferation-migration tradeoï¬€s on
phenotypic evolution in cancer, Scientiï¬c Reports, 9 (2019), pp. 1â€“10.
[33] I. Ganly, V. Mautner, and A. Balmain, Productive replication of human adenoviruses in mouse epidermal cells,
Journal of virology, 74 (2000), pp. 2895â€“2899.
[34] R. A. Gatenby, K. Smallbone, P. K. Maini, F. Rose, J. Averill, R. B. Nagle, L. Worrall, and R. J.
Gillies, Cellular adaptations to hypoxia and acidosis during somatic evolution of breast cancer, British Journal of
Cancer, 97 (2007), pp. 646â€“653.
[35] D. R. Grimes, C. Kelly, K. Bloch, and M. Partridge, A method for estimating the oxygen consumption rate
in multicellular tumour spheroids, Journal of The Royal Society Interface, 11 (2014), p. 20131124.
[36] A. L. Jenner, F. Frascoli, A. C. Coster, and P. S. Kim, Enhancing oncolytic virotherapy: Observations from
a voronoi cell-based model, Journal of Theoretical Biology, 485 (2020).
[37] A. L. Jenner, P. S. Kim, and F. Frascoli, Oncolytic virotherapy for tumours following a Gompertz growth law,
Journal of Theoretical Biology, 480 (2019), pp. 129â€“140.
[38] A. L. Jenner, M. Smalley, D. Goldman, W. F. Goins, C. S. Cobbs, R. B. Puchalski, E. A. Chiocca,
S. Lawler, P. Macklin, A. Goldman, and M. Craig, Agent-based computational modeling of glioblastoma
predicts that stromal density is central to oncolytic virus eï¬ƒcacy, iScience, 25 (2022).
[39] A. L. Jenner, C.-O. Yun, P. S. Kim, and A. C. F. Coster, Mathematical modelling of the interaction between
cancer cells and an oncolytic virus: Insights into the eï¬€ects of treatment protocols, Bulletin of Mathematical Biology,
80 (2018), pp. 1615â€“1629.
28
[40] K.-T. Jin, W.-L. Du, Y.-Y. Liu, H.-R. Lan, J.-X. Si, and X.-Z. Mou, Oncolytic virotherapy in solid tumors:
The challenges and achievements, Cancers, 13 (2021), pp. 1â€“28.
[41] G. P. Karev, A. S. Novozhilov, and E. V. Koonin, Mathematical modeling of tumor therapy with oncolytic
viruses: Eï¬€ects of parametric heterogeneity on cell dynamics, Biology Direct, 1 (2006).
[42] L. D. Ke, Y.-X. Shi, S.-A. Im, X. Chen, and W. A. Yung, The relevance of cell proliferation, vascular endothelial
growth factor, and basic ï¬broblast growth factor production to angiogenesis and tumorigenicity in human glioma cell
lines, Clinical Cancer Research, 6 (2000), pp. 2562â€“2572.
[43] E. Kelly and S. Russell, History of oncolytic viruses: Genesis to genetic engineering, Molecular Therapy, 15
(2007).
[44] J.-H. Kim, Y.-S. Lee, H. Kim, J.-H. Huang, A.-R. Yoon, and C.-O. Yun, Relaxin expression from tumor-
targeting adenoviruses and its intratumoral spread, apoptosis induction, and eï¬ƒcacy, Journal of the National Cancer
Institute, 98 (2006), pp. 1482â€“1493.
[45] Y. Kim, H. G. Lee, N. Dmitrieva, J. Kim, B. Kaur, and A. Friedman, Choindroitinase ABC I-mediated
enhancement of oncolytic virus spread and anti tumor eï¬ƒcacy: A mathematical model, PloS one, 9 (2014), p. e102499.
[46] N. L. Komarova and D. Wodarz, ODE models for oncolytic virus dynamics, Journal of theoretical biology, 263
(2010), pp. 530â€“543.
[47] S. E. Lawler, M.-C. Speranza, C.-F. Cho, and E. A. Chiocca, Oncolytic viruses in cancer treatment: A
review, JAMA Oncology, 3 (2017), pp. 841â€“849.
[48] H. Lodish, A. Berk, C. A. Kaiser, C. Kaiser, M. Krieger, M. P. Scott, A. Bretscher, H. Ploegh,
P. Matsudaira, et al., Molecular cell biology, Macmillan, 2008.
[49] T. Lorenzi and K. J. Painter, Trade-oï¬€s between chemotaxis and proliferation shape the phenotypic structuring
of invading waves, International Journal of Non-Linear Mechanics, 139 (2022).
[50] T. Lorenzi, E. Paparelli, and A. Tosin, Modelling coevolutionary dynamics in heterogeneous SI epidemiological
systems across scales. preprint, 2023.
[51] T. Lorenzi, B. Perthame, and X. Ruan, Invasion fronts and adaptive dynamics in a model for the growth of cell
populations with heterogeneous mobility, European Journal of Applied Mathematics, (2021).
[52] T. Lorenzi, A. Pugliese, M. Sensi, and A. Zardini, Evolutionary dynamics in an si epidemic model with
phenotype-structured susceptible compartment, Journal of Mathematical Biology, 83 (2021).
[53] T. Lorenzi, C. Venkataraman, A. Lorz, and M. A. J. Chaplain, The role of spatial variations of abiotic
factors in mediating intratumour phenotypic heterogeneity, Journal of theoretical biology, 451 (2018), pp. 101â€“110.
[54] A. Lorz, S. Mirrahimi, and B. Perthame, Dirac mass dynamics in multidimensional nonlocal parabolic equations,
Communications in Partial Diï¬€erential Equations, 36 (2011), pp. 1071â€“1098.
[55] A. MartÂ´Ä±nez-GonzÂ´alez, G. F. Calvo, L. A. PÂ´erez Romasanta, and V. M. PÂ´erez-GarcÂ´Ä±a, Hypoxic cell
waves around necrotic cores in glioblastoma: a biomathematical model and its therapeutic implications, Bulletin of
Mathematical Biology, 74 (2012), pp. 2875â€“2896.
[56] S. R. McKeown, Deï¬ning normoxia, physoxia and hypoxia in tumoursâ€”implications for treatment response, The
British Journal of Radiology, 87 (2014), p. 20130676.
[57] W. Mok, T. Stylianopoulos, Y. Boucher, and R. K. Jain, Mathematical modeling of herpes simplex virus
distribution in solid tumors: Implications for cancer gene therapy, Clinical Cancer Research, 15 (2009), pp. 2352â€“
2360.
[58] D. Morselli, M. E. Delitala, and F. Frascoli, Agent-based and continuum models for spatial dynamics of
infection by oncolytic viruses, Bulletin of Mathematical Biology, 85 (2023).
[59] W. Mueller-Klieser and R. Sutherland, Oxygen consumption and oxygen diï¬€usion properties of multicellular
spheroids from two diï¬€erent cell lines, Advances in Experimental Medicine and Biology, 180 (1984), pp. 311â€“321.
29
[60] W. I. Newman, Some exact solutions to a non-linear diï¬€usion problem in population genetics and combustion,
Journal of Theoretical Biology, 85 (1980), pp. 325â€“334.
[61] A. S. Novozhilov, F. S. Berezovskaya, E. V. Koonin, and G. P. Karev, Mathematical modeling of tumor
therapy with oncolytic viruses: Regimes with complete tumor elimination within the framework of deterministic
models, Biology Direct, 1 (2006), pp. 1â€“18.
[62] L. R. Paiva, C. Binny, S. C. Ferreira Jr, and M. L. Martins, A multiscale mathematical model for oncolytic
virotherapy, Cancer Research, 69 (2009), pp. 1205â€“1211.
[63] B. Perthame, Transport equations in biology, Springer Science & Business Media, 2006.
[64] B. Perthame and G. Barles, Dirac concentrations in lotka-volterra parabolic pdes, Indiana University Mathe-
matics Journal, 57 (2008), pp. 3275â€“3301.
[65] R. N. Pittman, Regulation of tissue oxygenation, Colloquium Series on Integrated Systems Physiology: From
Molecule to Function, 3 (2011), pp. 1â€“100.
[66] P. Pooladvand and P. S. Kim, Modelling oncolytic virus diï¬€usion in collagen-dense tumours, Frontiers in Systems
Biology, 2 (2022).
[67] P. Pooladvand, C.-O. Yun, A.-R. Yoon, P. S. Kim, and F. Frascoli, The role of viral infectivity in oncolytic
virotherapy outcomes: A mathematical study, Mathematical Biosciences, 334 (2021), p. 108520.
[68] T. Ramaj and X. Zou, On the treatment of melanoma: a mathematical model of oncolytic virotherapy, Mathemat-
ical Biosciences, 365 (2023).
[69] H. L. Rocha, I. Godet, F. Kurtoglu, J. Metzcar, K. Konstantinopoulos, S. Bhoyar, D. M. Gilkes,
and P. Macklin, A persistent invasive phenotype in post-hypoxic tumor cells is revealed by fate mapping and
computational modeling, Science, 24 (2021), pp. 1â€“22.
[70] L. Russell and K.-W. Peng, The emerging role of oncolytic virus therapy against cancer, Chinese Clinical On-
cology, 7 (2018).
[71] M. Sadri, A. Najafi, A. Rahimi, N. Behranvand, M. Hossein Kazemi, H. Khorramdelazad, and R. Falak,
Hypoxia eï¬€ects on oncolytic virotherapy in cancer: Friend or foe?, International Immunopharmacology, 122 (2023),
p. 110470.
[72] L. A. Santry, J. P. van Vloten, J. P. Knapp, K. Matuszewska, T. M. McAusland, J. A. Minott, R. C.
Mould, A. A. Stegelmeier, P. P. Major, S. K. Wootton, J. J. Petrik, and B. W. Bridle, Tumour
vasculature: Friend or foe of oncolytic viruses?, Cytokine & Growth Factor Reviews, 56 (2020), pp. 69â€“82.
[73] Z. Sheng Guo, The impact of hypoxia on oncolytic virotherapy, Virus Adaptation and Treatment, 3 (2011), pp. 71â€“
82.
[74] K. M. Storey and T. L. Jackson, An agent-based model of combination oncolytic viral therapy and anti-PD-1
immunotherapy reveals the importance of spatial location when treating glioblastoma, Cancers, 13 (2021).
[75] K. M. Storey, S. E. Lawler, and T. L. Jackson, Modeling oncolytic viral therapy, immune checkpoint inhibition,
and the complex dynamics of innate andaadaptive immunity in glioblastoma treatment, Frontiers in Physiology, 11
(2020).
[76] A. Surendran, A. L. Jenner, E. Karimi, B. Fiset, D. F. Quail, L. A. Walsh, and M. Craig, Agent-
cased modelling reveals the role of the tumor microenvironment on the short-term success of combination temozolo-
mide/immune checkpoint blockade to treat glioblastoma, Journal of Pharmacology and Experimental Therapeutics,
387 (2023), pp. 66â€“77.
[77] C. Villa, M. A. J. Chaplain, and T. Lorenzi, Modeling the emergence of phenotypic heterogeneity in vascularized
tumors, SIAM Journal on Applied Mathematics, 81 (2021), pp. 434â€“453.
[78]
, Modeling the emergence of phenotypic heterogeneity in vascularized tumors, SIAM Journal on Applied Math-
ematics, 81 (2021), pp. 434â€“453.
30
[79] G. Vithanage, H.-C. Wei, and S. R.-J. Jang, The role of tumor activation and inhibition with saturation eï¬€ects
in a mathematical model of tumor and immune system interactions undergoing oncolytic viral therapy, Mathematical
Methods in the Applied Sciences, 46 (2023), pp. 10787â€“10813.
[80] B. A. Wagner, S. Venkataraman, and G. R. Buettner, The rate of oxygen utilization by cells, Free Radical
Biology and Medicine, 51 (2011), pp. 700â€“712.
[81] D. Wodarz, Viruses as antitumor weapons: Deï¬ning conditions for tumor remission, Cancer Research, 61 (2001),
pp. 3501â€“3507.
[82] D. Wodarz, A. Hofacre, J. W. Lau, Z. Sun, H. Fan, and N. L. Komarova, Complex spatial dynamics
of oncolytic viruses in vitro: Mathematical and experimental approaches, PLoS Computational Biology, 8 (2012),
p. e1002547.
[83] J. Wojton and B. Kaur, Impact of tumor microenvironment on oncolytic viral therapy, Cytokine and Growth
Factor Reviews, 21 (2010), pp. 127â€“134.
[84] S. T. Workenhe, G. Simmons, J. G. Pol, B. D. Lichty, W. P. Halford, and K. L. Mossman, Immunogenic
HSV-mediated oncolysis shapes the antitumor immune response and contributes to therapeutic eï¬ƒcacy, Molecular
Therapy, 22 (2014), pp. 123â€“131.
[85] J. T. Wu, H. M. Byrne, D. H. Kirn, and L. M. Wein, Modeling and analysis of a virus that replicates selectively
in tumor cells, Bulletin of Mathematical Biology, 63 (2001), pp. 731â€“768.
[86] J. T. Wu, D. H. Kirn, and L. M. Wein, Analysis of a three-way race between tumor growth, a replication-competent
virus and an immune response, Bulletin of Mathematical Biology, 66 (2004), pp. 605â€“625.
[87] Y. Zhuang, K. Liu, Q. He, X. Gu, C. Jiang, and J. Wu, Hypoxia signaling in cancer: Implications for therapeutic
interventions, MedComm, 4 (2023), p. 110470.
31
